WO2021212149A1 - Self-disinfecting face shield - Google Patents

Self-disinfecting face shield Download PDF

Info

Publication number
WO2021212149A1
WO2021212149A1 PCT/US2021/070409 US2021070409W WO2021212149A1 WO 2021212149 A1 WO2021212149 A1 WO 2021212149A1 US 2021070409 W US2021070409 W US 2021070409W WO 2021212149 A1 WO2021212149 A1 WO 2021212149A1
Authority
WO
WIPO (PCT)
Prior art keywords
sulfonated
face
face shield
polymer
face panel
Prior art date
Application number
PCT/US2021/070409
Other languages
French (fr)
Inventor
Vijay Mhetar
Richard Blackwell
Roger TOCCHETTO
Sharman Mcgilbert
Bert KRUTZER
Original Assignee
Kraton Polymers Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kraton Polymers Llc filed Critical Kraton Polymers Llc
Priority to CN202180028933.XA priority Critical patent/CN115484845A/en
Priority to JP2022562731A priority patent/JP2023522333A/en
Priority to EP21727067.7A priority patent/EP4110126A1/en
Publication of WO2021212149A1 publication Critical patent/WO2021212149A1/en
Priority to US18/047,123 priority patent/US20230085444A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1184Protective face masks, e.g. for surgical use, or for use in foul atmospheres with protection for the eyes, e.g. using shield or visor
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1161Means for fastening to the user's head
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1192Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent

Definitions

  • the disclosure relates to a self-disinfecting face shield, having a protective anti- microbial layer.
  • microbes e.g., viruses, bacteria, etc.
  • people use face shields or face masks to prevent inhalation or entry of microbes.
  • microbes such as viruses or bacteria would accumulate on an outer surface of the face shield, and may remain active for relatively long duration. These viruses or bacteria may contact the hands of the wearer, when the wearer removes the face shield, and subsequently may find their way inside the human body, which is undesirable.
  • a self-disinfecting face shield comprises: a transparent face panel configured to extend facing at least a portion of a face of a wearer, the transparent face panel comprising a substrate having a first surface adapted to be disposed facing the face of the wearer and second surface disposed opposite to the first surface. At least one of first surface and the second surface is protected by a sulfonated polymeric layer for killing at least 90% microbes within 120 minutes of contact with the transparent face panel.
  • the sulfonated polymeric layer comprises, or consists essentially, or consists of a sulfonated polymer, the sulfonated polymer from the group of perfluorosulfonic acid polymers, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyesters, sulfonated polysulfones, sulfonated polyketones, sulfonated poly(arylene ether), and mixtures thereof.
  • the sulfonated polymeric layer has a thickness of at least > 1 pm.
  • the sulfonated polymeric layer comprises at least 50 wt.%, more preferably at least 70 wt.%, even more preferably at least 90 wt.%, yet more preferably at least 95 wt.%, still more preferably at least 98 wt.%, even more preferably at least 99 wt.% and most preferably 100 wt.% (i.e. consists) of one or more of the sulfonated polymers.
  • the sulfonated polymer is a selectively sulfonated negative- charged anionic block copolymer, having at least one alkenyl arene polymer block A and at least one substantially completely, hydrogenated conjugated diene polymer block B, with substantially all of the sulfonic functional groups grafted to alkenyl arene polymer block A for the block A to be a hydrophilic end-block.
  • the sulfonated polymeric layer is applied onto the second surface by dip coating, spray coating, dispersion coating, solvent casting, or adhesively attached to the second surface as a peel-and-stick film.
  • the face shield further comprises an attachment structure coupled to the face panel and configured to secure the face panel in front of the face of the wearer.
  • FIG. 1 illustrates a sectional view of a face panel of an embodiment of the face shield depicting a first polymeric film attached to a transparent laminate.
  • FIG. 2 is a perspective view of an embodiment of a face shield.
  • FIG. 3 is a perspective view of an embodiment of a face shield.
  • FIG. 4 is a perspective view of an embodiment of a face shield.
  • FIG. 5 is a perspective view of an embodiment of a face shield.
  • FIG. 6 is a perspective view of an embodiment of a face shield.
  • FIG. 7 is a perspective view of an attachment structure of the face shield of FIG.6.
  • FIG. 8 is a perspective view of an embodiment of a face shield.
  • FIG. 9 is a perspective view of an embodiment of a face shield.
  • FIG. 10 is a perspective view of an embodiment of a face shield.
  • FIG. 11 is a perspective view of an embodiment of a face shield. DETAILED DESCRIPTION
  • Effective amount refers to an amount sufficient to alter, destroy, inactivate, and / or neutralize microbes, e.g., an amount sufficient to sterilize and kill microbes in contact with outer surface of the face panel in a face shield.
  • Fogging can be evaluated by directly breathing onto a face shield held approximately one inch from the mouth. Fogging is determined subjectively to be (i) “excellent if no fogging of the film was observed; (ii) fair if fogging is observed but dissipated within 2 seconds; or (iii) poor if fogging persisted more than 2 seconds. If excellent or fair, a coating is said to have anti-fogging properties.
  • Anti-fog property can be expressed by T f0 , which is the time in minutes it takes to form a fog on a surface, e.g., exposing a layer (surface) to steam from boiling water at a 20 centimeter distance from the water’s surface in an environment of 50% RH (relative humidity) and 22° C.
  • T f0 the time in minutes it takes to form a fog on a surface
  • RH relative humidity
  • Haze means the percentage of transmitted light that upon passing through a specimen is scattered greater than 2.5 degrees from the normal. Haze and transmittance can be measured according to ASTM D1003 test method. A higher haze value indicates greater scattering.
  • IEC Ion Exchange Capacity
  • EW Equivalent weight
  • Merobes refers to microorganisms including bacteria, archaea, fungi (yeasts and molds), algae, protozoa, and viruses, with microscopic size.
  • peel-and-stick or “peel-and-stick film” refers to a laminate having at least two layers, a release layer or liner which can also be a support layer, and another layer containing the sulfonated polymer.
  • the peel-and-stick is self-adhesive, or releasable or peelable, or removable after being attached to a surface.
  • the release layer is optionally coated with an adhesive which permits it to stick to a surface without glue, paste, or the like, allowing the peel-and-stick to be separable after being applied onto a surface.
  • the layer containing the sulfonated polymer is optionally coated with an adhesive for the layer stick to surface, but is still releasable.
  • “Releasable” or “separable” bond in the context of layers or surfaces means that the layers or surfaces are generally attached or fastened to each other, yet can be separated with the application of a certain amount of force, and then subsequently refastened or reattached at a later time.
  • the surfaces In order to be “separable” or “releasable,” the surfaces must be capable of being fastened and separated, and the force applied to separate the layers or surfaces can be applied by hand.
  • “Surface pH” refers to the pH on the contact surface of the bio-secure material, that results from surface bound moieties e.g., the coating layer.
  • the surface pH can be measured with commercial surface pH measuring instruments, e.g., SenTixTM Sur-electrode from WTW Scientific-Technical Institute GmbH, Weilheim, Germany.
  • the disclosure relates to a face shield having a protective antimicrobial layer that kills microbes within a predefined duration of contact.
  • the face shield has a transparent panel with its surface (away from the wearer’s face) being coated or protected with a layer comprising a self-sterilizing (self-disinfecting) sulfonated polymeric material.
  • the portion of the face shield directed to the wearer can also be coated or protected with a self-sterilizing material, a sulfonated polymer.
  • the protective material comprises, consists essentially of, or consists of a sulfonated polymer.
  • the sulfonated polymer coats the surface of the transparent face panel for killing at least 95% microbes within a pre-defmed duration of contact.
  • the face shield includes an attachment structure to secure the transparent panel in front of the face of the wearer.
  • Sulfonated polymer refers to polymers having a sulfonate group, e.g., — SO 3 , either in the acid form (e.g., — SO 3 H, sulfonic acid) or a salt form (e.g., — SCbNa).
  • sulfonated polymer also covers sulfonate containing polymers, e.g., polystyrene sulfonate.
  • the sulfonated polymer is selected from the group of perfluorosulfonic acid polymers (e.g., sulfonated tetrafluoroethylene), sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyester, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polysulfones such as polyether sulfone, sulfonated polyketones such as polyether ether ketone, sulfonated polyphenylene ethers, and mixtures thereof.
  • perfluorosulfonic acid polymers e.g., sulfonated tetrafluoroethylene
  • sulfonated polyolefins e.g., sulfonated polyolefins, sul
  • the sulfonated polymer is characterized as being sufficiently or selectively sulfonated to contain from 10 - 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units or the block to be sulfonated (“degree of sulfonation”), to kill at least 95% of microbes within 120 minutes of coming into contact with the coating material.
  • the sulfonated polymer has a degree of sulfonation of > 25 mol %, or > 50 mol %, or ⁇ 95 mol %, or 25-70 mol %. Degree of sulfonation can be calculated by NMR or ion exchange capacity (IEC).
  • the sulfonated polymer is a sulfonated tetrafluoroethylene, having a polytetrafluoroethylene (PTFE) backbone; (2) side chains of vinyl ethers (e.g.,
  • the sulfonated polymer is a polystyrene sulfonate
  • examples include potassium polystyrene sulfonate, sodium polystyrene sulfonate, a co-polymer of sodium polystyrene sulfonate and potassium polystyrene sulfonate (e.g., a polystyrene sulfonate copolymer), having a molecular weight of 20,000 to 1,000,000 Daltons, or > 25,000 Daltons, or > 40,000 Dalton, or > 50,000, or > 75,000, or > 100,000 Daltons, or > 400,000 Daltons, or ⁇ 200,000, or ⁇ 800,000 Daltons, or up to 1,500,000 Daltons.
  • the polystyrene sulfonate polymers can either be crosslinked or uncrosslinked. In embodiments, the polystyrene sulfonate polymers are uncrosslinked and water soluble.
  • the sulfonated polymer is a polysulfone, selected from the group of aromatic polysulfones, polyphenylenesulfones, aromatic polyether sulfones, dichlorodiphenoxy sulfones, sulfonated substituted polysulfone polymers, and mixtures thereof.
  • the sulfonated polymer is a sulfonated polyethersulfone copolymer, which can be made with reactants including sulfonate salts such as hydroquinone 2-potassium sulfonate (HPS) with other monomers, e.g., bisphenol A and 4-fluorophenyl sulfone.
  • HPS hydroquinone 2-potassium sulfonate
  • the degree of sulfonation in the polymer can be controlled with the amount of HPS unit in the polymer backbone.
  • the sulfonated polymer is a sulfonated polyether ketone.
  • the sulfonated polymer is a sulfonated polyether ketone ketone (SPEKK), obtained by sulfonating a polyether ketone ketone (PEKK).
  • SPEKK polyether ketone ketone
  • the polyether ketone ketone can be manufactured using diphenyl ether and a benzene dicarbonic acid derivative.
  • the sulfonated PEKK can be available as an alcohol and / or water-soluble product, e.g., for subsequent use to coat the face mask or in spray applications.
  • the sulfonated polymer is a sulfonated poly(arylene ether) copolymer containing pendant sulfonic acid groups.
  • the sulfonated polymer is a sulfonated poly(2,6-dimethyl-l,4-phenylene oxide), commonly referred to as sulfonated polyphenylene oxide.
  • the sulfonated polymer is a sulfonated poly(4- phenoxybenzoyl-1, 4-phenyl ene) (S-PPBP).
  • the sulfonated polymer is a sulfonated polyphenylene having 2 to 6 pendant sulfonic acid groups per polymer repeat, and characterized as having 0.5 meq (SCbHyg of polymer to 5.0 meq (SCbHj/g polymer, or at least 6 meq/g (SCbHj/g polymer.
  • the sulfonated polymer is a sulfonated polyamide, e.g. aliphatic polyamides such nylon-6 and nylon-6,6, partially aromatic polyamides and polyarylamides such as poly(phenyldiamidoterephthalate), provided with sulfonate groups chemically bonded as amine pendant groups to nitrogen atoms in the polymer backbone.
  • the sulfonated polyamide can have a sulfonation level of 20 to up to 100% of the amide group, with the sulfonation throughout the bulk of the polyamide.
  • the sulfonation is limited to a high density of sulfonate groups at the surface, e.g., > 10%, > 20%, > 30%, or > 40%, or up to 100% of the sulfonated amide group at the surface (within 50 nm of the surface).
  • the sulfonated polymer is a sulfonated polyolefin, containing at least 0.1 meq, or > 2 meq, or > 3 meq, or > 5 meq, or 0.1 to 6 meq of sulfonic acid per gram of polyolefin.
  • the sulfonated polymer is a sulfonated polyethylene.
  • the sulfonated polyolefin can be formed by chlorosulfonation of a solid polyolefin obtained by polymerization of an olefin or a mixture of olefins selected from a group consisting of ethylene, propylene, butene- 1,4-methylpentene-l, isobutylene, and styrene.
  • the sulfonyl chloride groups can then be hydrolyzed, for example, in an aqueous base such as potassium hydroxide or in a water dimethylsulfoxide (DMF) mixture to form sulfonic acid groups.
  • the sulfonated polyolefin is formed by submerging or passing polyolefin object in any form of powder, fiber, yarn, woven fabric, a film, a preform, etc., through a liquid containing sulfur trioxide (SO 3 ), a sulfur trioxide precursor (e.g., chlorosulfonic acid, HSO 3 CI), sulfur dioxide (SO 2 ), or a mixture thereof.
  • SO 3 sulfur trioxide
  • a sulfur trioxide precursor e.g., chlorosulfonic acid, HSO 3 CI
  • sulfur dioxide SO 2
  • the polyolefin object is brought into contact with a sulfonating gas, e.g., SO 2 or SO 3 , or gaseous reactive precursor, or a sulfonation additive that evolves a gas SO x at elevated temperature.
  • the polyolefin precursor to be sulfonated can be, for example, a poly-a-olefm, such as polyethylene, polypropylene, polybutylene, polyisobutylene, ethylene propylene rubber, or a chlorinated polyolefin (e.g., polyvinylchloride, or PVC), or a polydiene, such as polybutadiene (e.g., poly-1, 3-butadiene or poly- 1,2-butadiene), polyisoprene, dicyclopentadiene, ethylidene norbornene, or vinyl norbornene, or a homogeneous or heterogeneous composite thereof, or a copolymer thereof (e.g., EPDM rubber, i.e., ethylene propylene diene monomer).
  • a poly-a-olefm such as polyethylene, polypropylene, polybutylene, polyisobutylene, ethylene propylene rubber, or
  • the polyolefin is selected from low density polyethylene (LDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE), high density polyethylene (HDPE), medium density polyethylene (MDPE), high molecular weight polyethylene (HMWPE), and ultra-high molecular weight polyethylene (UHMWPE).
  • LDPE low density polyethylene
  • LLDPE linear low density polyethylene
  • VLDPE very low density polyethylene
  • HDPE high density polyethylene
  • MDPE medium density polyethylene
  • HMWPE high molecular weight polyethylene
  • UHMWPE ultra-high molecular weight polyethylene
  • the sulfonated polymer is a sulfonated polyimide, e.g., aromatic polyimides in both thermoplastic and thermosetting forms, having excellent chemical stability and high modulus properties.
  • Sulfonated polyimide can be prepared by condensation polymerization of dianhydrides with diamines, wherein one of the monomeric units contains sulfonic acid, sulfonic acid salt, or sulfonic ester group.
  • the polymer can also be prepared by direct sulfonation of aromatic polyimide precursors, using sulfonation agents such as chlorosulfonic acid, sulfur trioxide and sulfur trioxide complexes.
  • the concentration of sulfonic acid groups in the sulfonated polyimide as measured by ion exchange capacity, IEC, varying from 0.1 meq/g to above 3 meq/g, or at least 6 meq/g.
  • the sulfonated polymer is a sulfonated polyester, formed by directly sulfonating a polyester resin in any form, e.g., fiber, yarn, woven fabric, film, sheet, and the like, with a sulfuric anhydride-containing gas containing sulfuric anhydride, for a concentration of the sulfone group on the surface of the polyester ranging from 0.1 meq/g to above 3 meq/g, e.g., up to 5 meq/g, or at least 6 meq/g.
  • the sulfonated polymer is a selectively sulfonated negative- charged anionic block copolymer.
  • the sulfonate group can be in the form of metal salt, ammonium salt or amine salt.
  • the sulfonated polymer can be modified (or funcationalized).
  • the sulfonated polymer is neutralized with any of various metal counterions, including alkali, alkaline earth, and transition metals, with at least 10% of the sulfonic acid groups being neutralized.
  • the sulfonated polymer is neutralized with inorganic or organic cationic salts, e.g, those based on ammonium, phosphonium, pyridinium, sulfonium and the like. Salts can be monomeric, oligomeric, or polymeric.
  • the sulfonated polymer is neutralized with various primary, secondary, or tertiary amine-containing molecules, with > 10% of the sulfonic acid or sulfonate functional groups being neutralized.
  • the sulfonic acid or sulfonate functional group is modified by reaction with an effective amount of polyoxyalkyleneamine having molecular weights from 140 to 10,000.
  • Amine-containing neutralizing agents can be mono-functional or multi-functional; monomeric, oligomeric, or polymeric.
  • the sulfonated polymer is modified with alternative anionic functionalities, such as phosphonic acid or acrylic and alkyl acrylic acids.
  • amine containing polymers are used for the modification of the sulfonated polymers, forming members of a class of materials termed coaservates.
  • the neutralizing agent is a polymeric amine, e.g., polymers containing benzylamine functionality. Examples include homopolymers and copolymers of 4-dimethylaminostyrene which has been described in US Patent 9,849,450, incorporated herein by reference.
  • the neutralizing agents are selected from polymers containing vinylbenzylamine functionality, e.g., polymers synthesized from poly-p-methyl styrene containing block copolymers via a bromination-amination strategy, or by direct anionic polymerization of amine containing styrenic monomers.
  • amine functionalities for functionalization include but are not limited to p - vinylbenzyldimethylamine (BDMA ), p - vinylbenzylpyrrolidine (VBPyr ), p - vinylbenzyl- bis(2-methoxyethyl)amine (VBDEM ), p-vinylbenzylpiperazine (VBMPip ), and p- vinylbenzyldiphenylamine (VBDPA).
  • BDMA p - vinylbenzyldimethylamine
  • VBPyr p - vinylbenzylpyrrolidine
  • VBPyr p - vinylbenzyl- bis(2-methoxyethyl)amine
  • VBMPip p-vinylbenzylpiperazine
  • VBDPA p- vinylbenzyldiphenylamine
  • corresponding phosphorus containing polymers can also be used for the functionalization of the sulfonated polymers.
  • the monomer or the block containing amine functionality or phosphine functionality can be neutralized with acids or proton donors, creating quaternary ammonium or phosphonium salts.
  • the sulfonated polymer containing tertiary amine is reacted with alkylhalides to form functional groups, e.g., quatemized salts.
  • the sulfonated polymer can contain both cationic and anionic functionality to form so-called zwitterionic polymers.
  • the sulfonated polymer is a selectively sulfonated negative-charged anionic block copolymer, which “selectively sulfonated” definition to include sulfonic acid as well as neutralized sulfonate derivatives.
  • the sulfonate group can be in the form of metal salt, ammonium salt or amine salt.
  • the sulfonated block polymer has a general configuration A-B-A, (A-B) n (A), (A-B-A) n , (A-B-A) n X, (A-B) n X, A-D-B, A-B-D, A-D- B-D-A, A-B-D-B-A, (A-D-B) n A, (A-B-D) n A (A-D-B ) n X, (A-B-D) n X or mixtures thereof; where n is an integer from 0 to 30, or 2 to 20 in embodiments; and X is a coupling agent residue.
  • Each A and D block is a polymer block resistant to sulfonation.
  • Each B block is susceptible to sulfonation.
  • the plurality of A blocks, B blocks, or D blocks can be the same or different.
  • the A blocks are one or more segments selected from polymerized (i) para-substituted styrene monomers, (ii) ethylene, (iii) alpha olefins of 3 to 18 carbon atoms; (iv) 1,3 -cyclodiene monomers, (v) monomers of conjugated dienes having a vinyl content less than 35 mol percent prior to hydrogenation, (vi) acrylic esters, (vii) methacrylic esters, and (viii) mixtures thereof. If the A segments are polymers of 1,3 -cyclodiene or conjugated dienes, the segments will be hydrogenated subsequent to polymerization of the block copolymer and before sulfonation of the block copolymer.
  • the A blocks may also contain up to 15 mol % of the vinyl aromatic monomers such as those present in the B blocks.
  • the A block is selected from para-substituted styrene monomers selected from para-methylstyrene, para-ethyl styrene, para-n-propyl styrene, para-iso- propyl styrene, para-n -butyl styrene, para-sec-butyl styrene, para-iso-butyl styrene, para-t- butylstyrene, isomers of para-decyl styrene, isomers of para-dodecyl styrene and mixtures of the above monomers.
  • para-substituted styrene monomers selected from para-methylstyrene, para-ethyl styrene, para-n-propyl styrene, para-iso- propyl styrene, para-n -butyl
  • para-substituted styrene monomers examples include para-t-butyl styrene and para-methylstyrene, with para-t-butyl styrene being most preferred.
  • Monomers may be mixtures of monomers, depending on the particular source. In embodiments, the overall purity of the para-substituted styrene monomers be at least 90%-wt., or > 95%-wt., or > 98%-wt. of the para-substituted styrene monomer.
  • the block B comprises segments of one or more polymerized vinyl aromatic monomers selected from unsubstituted styrene monomer, ortho- substituted styrene monomers, meta- substituted styrene monomers, alpha-methylstyrene monomer, 1,1- diphenyl ethylene monomer, 1,2-diphenyl ethylene monomer, and mixtures thereof.
  • the B blocks also comprises a hydrogenated copolymer of such monomer (s) with a conjugated diene selected from 1,3 -butadiene, isoprene and mixtures thereof, having a vinyl content of between 20 and 80 mol percent.
  • copolymers with hydrogenated dienes can be any of random copolymers, tapered copolymers, block copolymers or controlled distribution copolymers.
  • the block B is selectively sulfonated, containing from about 10 to about 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units. In embodiments, the degree of sulfonation in the B block ranges from 10 to 95 mol%, or 15 - 80 mol%, or 20 - 70 mol%, or 25 - 60 mol%, or > 20 mol%, or > 50 mol%.
  • the D block comprises a hydrogenated polymer or copolymer of a conjugated diene selected from isoprene, 1,3 -butadiene and mixtures thereof.
  • the D block is any of an acrylate, a silicone polymer, or a polymer of isobutylene with a number average molecular weight of > 1000, or >2000, or >4000, or >6000.
  • the coupling agent X is selected from coupling agents known in the art, including polyalkenyl coupling agents, dihaloalkanes, silicon halides, siloxanes, multifunctional epoxides, silica compounds, esters of monohydric alcohols with carboxylic acids, (e.g. methylbenzoate and dimethyl adipate) and epoxidized oils.
  • the antimicrobial and mechanical properties of the sulfonated block copolymer can be varied and controlled by varying the amount of sulfonation, the degree of neutralization of the sulfonic acid groups to the sulfonated salts, as well as controlling the location of the sulfonated group(s) in the polymer.
  • the sulfonated block copolymer can be selectively sulfonated for desired water dispersity properties or mechanical properties, e.g., having the sulfonic acid functional groups attached to the inner blocks or middle blocks, or in the outer blocks of a sulfonated block copolymer, as in US Patent No. US8084546, incorporated by reference.
  • outer (hard) blocks are sulfonated, upon exposure to water, hydration of the hard domains may result in plasticization of those domains and softening, allowing dispersion or solubility.
  • the sulfonated copolymer in embodiments is as disclosed in Patent Publication
  • the sulfonated block copolymer has a general configuration A- B-(B-A) I -5, wherein each A is a non-elastomeric sulfonated monovinyl arene polymer block and each B is a substantially saturated elastomeric alpha-olefin polymer block, said block copolymer being sulfonated to an extent sufficient to provide at least 1% by weight of sulfur in the total polymer and up to one sulfonated constituent for each monovinyl arene unit.
  • the sulfonated polymer can be used in the form of their acid, alkali metal salt, ammonium salt or amine salt.
  • the sulfonated block copolymer is a sulfonated polystyrene- polyisoprene-polystyrene, sulfonated in the center segment.
  • the sulfonated polymer is a sulfonated SBR (styrene butadiene rubber) as disclosed in US 6,110,616 incorporated by reference.
  • the sulfonated polymer is a water dispersible BAB triblock, with B being a hydrophobic block such as alkyl or (if it is sulfonated, it becomes hydrophilic) poly(t-butyl styrene) and A being a hydrophilic block such as sulfonated poly(vinyl toluene) as disclosed in US 4,505,827 incorporated by reference.
  • the sulfonated block copolymer is a functionalized, selectively hydrogenated block copolymer having at least one alkenyl arene polymer block A and at least one substantially completely, hydrogenated conjugated diene polymer block B, with substantially all of the sulfonic functional groups grafted to alkenyl arene polymer block A (as disclosed in US 5516831, incorporated by reference).
  • the sulfonated polymer is a water- soluble polymer, a sulfonated diblock polymer of t-butyl styrene / styrene, or a sulfonated triblock polymer of t-butyl styrene -styrene - t-butyl styrene as disclosed in US 4,492,785 incorporated by reference.
  • the sulfonated block copolymer is a partially hydrogenated block copolymer.
  • the sulfonated polymer is a midblock-sulfonated triblock copolymer, or a midblock-sulfonated pentablock copolymer or, e.g., a poly(p-tert-butylstyrene-b- styrenesulfonate -b-p-tert-butylstyrene), or a poly[tert-butylstyrene-b-(ethylene-alt-propylene)-b- (styrenesulfonate)-b-(ethylene-alt-propylene)-b-tert-butylstyrene.
  • the sulfonated polymer contains > 15 mol %, or > 25 mol %, or > 30 mol %, or > 40 mol %, or > 60 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units in the polymer that are available or susceptible for sulfonation, e.g., the styrene monomers.
  • the sulfonated polymer has an ion exchange capacity of > 0.5 meq/g, or > 0.75 meq/g, or > 1.0 meq/g, or > 1.5 meq/g, or > 2.0 meq/g, or > 2.5 meq/g, or ⁇ 5.0 meq/g.
  • the sulfonated polymer further contains or can be complexed with, or otherwise form mixtures, compounds, etc. with, antibiotics such as butylparaben and triclosan, e.g., antimicrobial surfactants, lipids, nanoparticles, peptides, antibiotics or antiviral drugs, quaternary ammonium and phosphonium containing polymers, chitosan and other naturally occurring antimicrobial polymers, ion-exchange resins, metallic- based micro and nano- structured materials such as silver, copper, zinc and titanium and their oxides, for enhanced antimicrobial effectiveness.
  • antibiotics such as butylparaben and triclosan
  • antimicrobial surfactants e.g., antimicrobial surfactants, lipids, nanoparticles, peptides, antibiotics or antiviral drugs, quaternary ammonium and phosphonium containing polymers, chitosan and other naturally occurring antimicrobial polymers, ion-exchange resins
  • the sulfonated polymer further comprises additives for decorative or safety effects, e.g., luminescent additives such as phosphorescent and fluorescence that would help or enable the sulfonated polymer layer to illuminate.
  • luminescent additives such as phosphorescent and fluorescence that would help or enable the sulfonated polymer layer to illuminate.
  • the optional additives are optical brighteners additives that illuminate under a special UV or black light tracer, allowing for physical inspections to verify that intended surfaces are coated or have remained intact, offering the intended antimicrobial / self-disinfecting effects.
  • the optical additives are UV stabilizers, e.g., UV absorbers, quenchers known in the art.
  • the sulfonated polymer further comprises additives that would help signal or give an indicator of its antimicrobial effects with a color change pH indicator.
  • additives that would help signal or give an indicator of its antimicrobial effects with a color change pH indicator. Examples include Thymol Blue, Methyl Orange, Bromocresol Green, Methyl Red, Bromothymol Blue, Phenol Red, and Phenol-phthalein.
  • a color change means a change in hue, from a light to a darker color or vice versa.
  • a color indicator may indicate if a recharge, regeneration, or reactivation of the antimicrobial activity of the protective layer is recommended.
  • the color indicator is incorporated in a sufficient amount so that a noticeable change in color hue is observed immediately when there is a change in the effectiveness of the sulfonated polymeric material, e.g., when its surface pH is increased above 2.0.
  • the amount of color indicator ranges from 0.1 to 20 wt.% of the amount of sulfonated polymer applied as a protective layer on the frequently-touched surface.
  • additives such as plasticizers, tackifiers, surfactants, film forming additives, dyes, pigments, cross-linkers, UV absorbers, catalysts, highly conjugated particles, sheets, or tubes (e.g. carbon black, graphene, carbon nanotubes), etc. may be incorporated in any combination to the extent that they do not reduce the efficacy of the material.
  • an antimicrobial sulfonated polymeric layer has a transmission rate of at least 90%, or at least 91%; or clarity of at least 99% or 99.5%; or a haze value of ⁇ 1.5%, or ⁇ 1.25%, or ⁇ 1.0%, or ⁇ 0.75%. Haze can be measured according to ASTM D-1003. This is in comparison with clear acrylic layers having transmission of 94.5%, haze of 0.1, and clarity of 100%.
  • the sulfonated polymer is characterized as having anti-fogging properties, with a T f0 of > 5 minutes , i.e., no fog is formed on a surface of substrates having sulfonated polymer coating within about 5 minutes.
  • the T f0g is > 15 minutes, or > 30 minutes.
  • the sulfonated polymer is characterized as being sufficiently sulfonated to have an IEC of > 0.5 meq/g, or 1.5 - 3.5 meq/g, or > 1.25 meq/g, or > 2.2 meq/g, or > 2.5 meq/g, or > 4.0 meq/g, or ⁇ 4.0 meq/g.
  • the sulfonated polymer is characterized as having a surface pH of ⁇ 3.0, or ⁇ 2.5, or ⁇ 2.25, or ⁇ 2.0, or ⁇ 1.80. It is believed that a sufficiently low surface level, as a result of the presence of sulfonic acid functional groups in the protective layer, would have catastrophic effects on microbes that come in contact with the surface.
  • the sulfonated polymer works effectively in destroying / inactivating at least 99%, or at least 99.5%, or at least 99.9% of microbes in ⁇ 30 minutes of exposure, or ⁇ 5 minutes of exposure or contact with microbes, including but not limited to MRSA, vancomycin-resistant Enterococcus faecium, X-MulV, PI-3, SARS-CoV-2, carbapenem- resistant Acinetobacter baumannii, and influenza A virus.
  • the material is effective in killing target microbes including Staphylococcus aureus, Escherichia coli, Staphylococcus albus, Escherichia coli, Rhizoctonia solani, and Fusarium oxysporum.
  • the sulfonated polymer remains effective in killing microbes even after 4 hours, or after 12 hours, or at least 24 hours, or for at least 48 hours.
  • the sulfonated polymer is a sulfonated block copolymer, e.g., a midblock-sulfonated pentablock copolymer, containing > 40 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units.
  • a sulfonated block copolymer e.g., a midblock-sulfonated pentablock copolymer, containing > 40 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units.
  • the sulfonated polymer can be applied as a protective coating on the transparent panel of the face shield as a coating, or as a self-adhesive protective film.
  • the sulfonated polymer can be applied onto the substrate before or after it is made into a face panel, and before or after the face panel is incorporated into the face shield, for a protective layer having a thickness of ⁇ 1000 pm, or > 1 pm, or > 5 pm, or > 10 pm, or ⁇ 500 pm, or ⁇ 200 pm, or ⁇ 100 pm, or 1 to 1000 pm, or 1 to 500 pm, or 1 to 200 pm, or 1 to 100 pm for a self-sterilizing surface.
  • the base or substrate (forming the face panel) is formed from a variety of materials. Examples include, but are not limited to, polyesters, such as polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycarbonates, allyl diglycolcarbonates, polyacrylates, such as polymethyl methacrylate, polystyrenes, cellulose acetate butyrate, glass, and combinations thereof.
  • the substrate can be any of a film, sheet, panel or pane of material, formed by known processes, such as blowing, casting, extrusion, injection molding, etc.
  • the thickness of the substrate is such that it is stiff enough to prevent collapse, yet flexible enough to bend, e.g., from 0.001 to 2 mm, or 0.01 to 0.5 mm, or 0.1 - 0.4 mm, or ⁇ 0.5 mm, or at least 0.05 mm.
  • the sulfonated polymer material is dispersed in a solvent in an amount up to 10 wt.%, or up to 20 wt. %, or up to 50 wt. %, for coating the base substrate as a protective layer.
  • exemplary solvents include but are not limited to water, isopropyl alcohol, acetone, N,N-dimethylacetamide, l-methyl-2- pyrrolidinone, 1,3-dioxolane, 2-methoxy ethanol, dimethylformamide, or benzyl alcohol.
  • the sulfonated polymer is applied by preparing a solution of the polymer in a suitable solvent, then casting on the substrate to be subsequently formed into face panels, with the thickness of the protective polymeric layer being adjusted with a casting knife, followed by drying.
  • the protective sulfonated polymeric layer is formed on the face panel by methods including but not limited to spray coating, or dip coating the substrate into a solution or dispersion containing the sulfonated polymer. Multiple coatings can be applied sequentially.
  • the face panels can be coated with the sulfonated polymeric material as individual pieces, or they can be formed from a large piece of coated substrate, cut into shapes forming face panels.
  • the sulfonated polymeric layer is applied on the face panel as a peel-and-stick film.
  • the peel-and-stick film is first peeled off to remove an optional support / release liner if present, and then applied directly onto the base substrate as a protective layer.
  • a squeegee or slight tap of finger may be used to remove trapped air between the film and the face panel.
  • the releasable peel-and-stick with the sulfonated polymeric protective layer can be peeled off, and replaced with a new peel-and-stick film for protection.
  • the sulfonated polymeric material is used to coat both the outer surface of the transparent face panel microbes upon contact, as well as in the inner surface which facing the wearer to minimize fog formation for extent wearing.
  • FIG. 1 illustrates an embodiment of a sectional construction of a face panel, with a protective antimicrobial polymer layer on a transparent substrate.
  • the face panel 102 has the antimicrobial polymer as a protective layer on both surfaces.
  • transparent substrate 140 has a first surface 142 (i.e. inner surface 142) adapted to be disposed facing a wearer (not shown) and a second surface 144 (i.e. outer surface 144) disposed opposite to the inner surface 142.
  • the sulfonated polymer is used to coat or applied onto both surfaces as first polymeric film 150 and second polymeric film 152.
  • the polymer film can be applied as a separate layer (e.g., by casting) or by coating both the first and second surfaces of the substrate 140, forming a laminate structure.
  • the first polymeric film 150 defines an outer surface 138 of the face panel 102, being exposed to microbes such as virus or bacteria.
  • the second polymeric film 152 is applied as engaged and abutted with the inner surface 142 of the substrate 140, and thereby defining the inner surface 136 facing the wearer of the face shield.
  • the first and second polymeric films can be the same or different sulfonated polymers.
  • the second polymeric film 152 comprises a sulfonated block copolymer material from Kraton Corporation with anti-fogging properties, allowing the wearer to better see through the face panel 102.
  • additional “fresh” or new layers of sulfonated polymeric film can be applied onto the first polymeric film as time goes on, for the face shield to continue functioning as a self-sterilizing protective gear.
  • FIG. 2 illustrates an embodiment of a face shield 100.
  • the face shield 100 includes a transparent face panel 102 adapted to be arranged in front of the face of a wearer 200 (not shown).
  • the face panel 102 can be flat, or substantially arcuate in shape, with a top edge 104, a bottom edge 106 disposed opposite to the top edge 104, a first side edge 108, and a second side edge 110.
  • the top edge 104 may be disposed proximate to forehead of wearer 200, while the bottom edge 106 is disposed distally from the forehead of wearer 200, when the face shield 100 is secured to the wearer 200. Accordingly, the bottom edge 106 may be disposed proximate to chin of the wearer relative to the top edge 104.
  • the first side edge 108 and the second side edge 110 extend from the top edge 104 to the bottom edge 106, and are disposed opposite to each other.
  • Face shield 100 may include an attachment structure 120 for securing the face panel 102 to the wearer 200, is adapted to position the face panel 120 in front of the face of wearer 200.
  • the attachment structure 120 is adapted to secure the face shield 100 to the wearer’s head, and includes a first strap 122 connected to the face panel 102 at a location proximate to the first side edge 108 and the top edge 102, and a second strap 124 connected to the face panel 102 at allocation proximate to the second side edge 110 and the top edge 102.
  • the attachment structure 120 includes a coupler 126 for attaching the first strap 122 to the second strap 124.
  • the coupler 126 may include a male member 128 attached to the first strap 122 and a female member 130 attached to the second strap 124 and adapted to removably engage with the male member 128.
  • the coupler 120 may be a hook and loop assembly having a hook member attached to the first strap 122 and a loop member attached to the second strap 124.
  • the first strap 122 and the second strap 124 may be adhesively attached to an inner surface 136 of the face panel 102.
  • the face panel 102 may include cut-outs extending from the inner surface 136 to the outer surface and arranged proximate to the side edges 108, 110, and the straps 122, 124 may be attached to the face panel 102 by inserting a portion of each of the straps 122, 124 through respective cut-outs and then making a knot. It may be appreciated that the straps 122, 124 may be attached to the face panel 102 by any mechanism or methods known in the art.
  • the attachment structure 120 may be a simple elastic strap with one end attached or tied to or near the top of the first side edge 108, and with the other end being attached or tied to or near the top of the second side edge 110.
  • the face panel 102 may be built-in as part of a protective garment, such as, personal protective equipment.
  • FIG. 3 illustrates an alternative embodiment of a face shield 300.
  • the face shield 300 is similar to the face shield 100, with the difference in the attachment structure 302 and in a foam member 306. It may be appreciated that the similar components of the face shields 100,
  • the attachment structure 302 is an elastic band 304 connected to the face panel 102 of the face shield 300 and is adapted to secure the face shield 300 to the head of the wearer 200, for the face panel 102 to be in front of the face of the wearer.
  • Foam member 306 is attached to an inner surface 136 of the face panel 102 and arranged proximate to a top edge 104 of the face panel 102. The foam member 306 provides a cushioning effect to the forehead of wearer 200 and can be removable.
  • FIG. 4 illustrates yet another alternative embodiment of a face shield 400, which is similar to the face shield 100, and with a different attachment structure 402. Similar components of the face shields 100, 300, and 400 are represented by identical reference numerals.
  • the attachment structure 402 includes a first strap 404 attached to a face panel 102 of the face shield 400, and extending outwardly from a first side edge 108, a second strap 406 attached to the face panel 102 and extending outwardly from the second side edge 110.
  • Coupler 408 is for for attaching the first strap 404 and the second strap 406.
  • the coupler 408 may be a buckle ring 410 attached to the first strap 404, adapted to be removably engaged with the second strap 406.
  • the buckle ring 410 may be attached to the first strap 404 by stitching, or by Velcro (not shown).
  • the second strap 406 is attached to the buckle ring 410 by inserting a portion of the second strap 406 inside the buckle ring 410 as known in the art.
  • the first strap 404 and the second strap 406 are integrally formed with each other and a portion of the strap is adhesively attached to the inner surface 136 of the face panel 102 (or by Velcro), and extend in an arcuate manner from the first side edge 108 to the second side edge 110.
  • FIG. 5 illustrates yet another embodiment of a face shield 500, with a different attachment structure 502.
  • Attachment structure 502 may be a frame 504 of an eyeglass attached to a face panel 506 of the face shield 500.
  • the face panel 506 is similar to the face panel 102 of the face shield 100 in function, with a transparent laminate.
  • the frame 504 includes two temples or arms 508, 510 arranged spaced apart from each other and extending outwardly of side edges 512, 514 of the face panel 506.
  • the first temple 508 extends from a first side edge 512, while the second temple 510 extends outwardly of a second side edge 514.
  • Frame 504 includes a bridge 520 adapted to be supported on a nose of the wearer 200, and nose pads 522, 524 secured under the bridge 520.
  • the nose pads 522, 524 are adapted to abut the nose of the wearer 200 and helps keep the frame 504, and hence the face panel 506, in place, while providing comfort and a snug fit.
  • the frame 504 includes a first arc portion 530 extending from the bridge 520 to the first temple 508, and a second arc portion 532 extending from the bridge 520 to the second temple 510.
  • the face panel 506 may be attached to the two arc portions 530, 532 such that the bridge 520, the nose pads 522, 524, and the arc portions 530, 532 are arranged between the face of the wearer 200 (not shown) and the face panel 506.
  • the two temples 508, 510 are adapted to rest on the ears of the wearer 200 to secure the face shield on the wearer 200.
  • the one or more or the bridge 520, the nose pads 522, 524, and the arc portions 530, 532 may abut the inner surface of the face panel 506, and may be engaged/attached with the face panel 506.
  • the frame 504 and the face panel 506 may be integrally formed.
  • the face panel 506 may be removably engaged with the frame 504.
  • the face shield 500 may include cushion pads (not shown) engaged with any of the arc portions 530, 532 and the bridge 520, and are adapted to contact the periphery of the eyes and the nose of the wearer 200 to provide cushioning effect.
  • FIG. 6 illustrates another embodiment of a face shield 600, with a face panel 602 attached to, or can be removably engaged with eyeglasses 604 via rim portions 630 and 632. Face panel 602 is similar to the face panel in other embodiments.
  • FIG. 7 illustrates an embodiment of protective eyeglasses 604 that can be used with a detachable face panel (not shown).
  • the eyeglasses include two temples or arms 608, 610 (not shown in FIG. 6) arranged spaced apart from each other and adapted to rest on the ears of the wearer 200, and a bridge 620 adapted to be supported on a nose of the wearer 200 (not shown).
  • Eyeglass 604 may include a first rim portion 630 extending from the bridge 620 to the first temple 608, and a second rim portion 632 extending from the bridge 620 to the second temple 610.
  • the eyeglass 604 may include a plurality of clips 640 (as shown in FIG. 7).
  • the face panel 602 may arranged between the rim portions 630, 632 and the cushion pad 638.
  • the face panel 602 (not shown) may be integrally formed with the rim portions 630 and 632
  • the eyeglass 604 may include a cushion pad 638 engaged with the rim portions 630, 632 and the bridge 620 and is adapted to contact, or seal around the periphery of the eyes and the nose of the wearer 200 to provide cushioning effect.
  • the lenses 634 and 636 can also be protected or coated with a layer of the sulfonated polymer.
  • FIG. 8 illustrates yet another a face shield 800, with components similar to the face shield 100 in FIG. 1 being represented by identical reference numerals.
  • Structure 802 includes a first arm 804 and second arm 806 arranged spaced apart and opposite to first arm 804, facilitating the securing of the face shield 800 to a wearer head (not shown).
  • the first arm 804 extends outwardly from a first side edge 108 and adapted to arranged substantially along a first side, for example, right side of the head and above the right shoulder.
  • the second arm 806 extends outwardly from a second side edge 110 and adapted to arranged substantially along a second side, for example, left side of the head and above the left shoulder.
  • Each arm 804, 806 may include an engagement structure, e.g., first engagement structure 808, such as, at least one first cut-out 810, and a second engagement structure 812, such as, at least one second cut-out 814, which can be adapted to engage with a drawstring or an ear loop, facilitating the secure of the face shield 800 to a wearer.
  • first engagement structure 808 such as, at least one first cut-out 810
  • second engagement structure 812 such as, at least one second cut-out 814
  • the face panel 102 includes a nose cavity and / or a cushion for the face panel to rest upon the nose of the wearer.
  • the first and second arms are shaped such that they fit around the ear lobes of the wearer, keeping the face shield secure for protecting the wearer’s face.
  • FIG. 9 illustrates yet another embodiment of a face shield 900, with a different attachment structure 902 from the attachment structure 120 in FIG. 1.
  • the attachment structure 902 includes a first arm 904 and second arm (not shown) arranged spaced apart and opposite to the first arm 902, facilitating the securing of the face shield 900 to the wearer’s head.
  • the first arm 902 extends outwardly from a first side edge 908 of a face panel 906 of the face shield 900 and adapted to arranged substantially along a first side, for example, a right side of the head and above the right shoulder.
  • the second arm extends outwardly from a second side edge of the face panel 906 and adapted to arranged substantially along a second side, for example, a left side of the head and above the left shoulder.
  • Each of the arms may include an engagement structure, for example, the first arm 902 includes an engagement structure 910, such as, a hole 912, to facilitate a securing of the face panel 906 in front of the face of the wearer 200.
  • Attachment structure 902 includes a cap 920 adapted to be arranged over the head of the wearer 200, and may include a retention structures, for example, a first retention structure 922 and a second retention structure (not shown) adapted to engage with the engagement structures of the first arm 902 and the second arm.
  • Retention structure 922 may be protrusion 924 extending outwardly from the cap 920.
  • First arm 902 and the second arm may be engaged with the cap 920, such that the protrusions 924 extend through the respective hole 912, for the face panel 906 to be supported on the respective protrusions 924 such that the face panel 906 can be pivoted relative to the cap 920 between a first position (e.g. upward position) and a second position (e.g. downward position).
  • the face panel 906 is formed or contoured corresponding to a profile of the face of the wearer 200.
  • FIG. 10 illustrates yet another face shield 1000, which includes a face panel 1002, a frame 1004 supporting the face panel 1002, and extending along the edges of the face panel 1002.
  • the face shield includes a cap (helmet or hat) 1006 adapted to be disposed on a head of the wearer (not shown) and pivotally coupled to the frame 1004.
  • the frame 1004 and the cap 1006 together define as attachment structure 1008 that secure the face shield 1000 to the wearer such that the face panel 1002 is arranged in front of the face of the wearer.
  • FIG. 11 illustrates another face shield embodiment 1100.
  • Face shield 1100 is adapted to cover only a portion of a face of a wearer (not shown).
  • the face shield 1100 includes a face panel 1102, and a frame 1104 supporting the face panel 1102 and extending along the edges of the face panel 1102 such that the frame 1104 surrounds the face panel 1102.
  • the face panel 1102 with a transparent laminate coated with the sulfonated polymeric layer is adapted to be disposed in front of the eyes of the wearer, therefore may act as protective eyeglasses as well.
  • frame 1104 may include a nose portion 1106 defining a nose cavity resting on the nose bridge of the wearer, when the face panel 1102 is secured on the face of the wearer 200.
  • Frame 1104 includes a top member 1108 adapted to extend along a forehead of the wearer 200, and two side members 1110, 1112 extending downwardly from the top member 1108.
  • Face shield 1100 may include a pad 1114 attached to the top member and adapted to abut the forehead of the wearer 200.
  • the pad 1114 may include a rubber based material providing a cushioning effect.
  • the face shield can also be one-piece with the attachment structure being integral with the substrate which forms the face panel, or a face shield connected to a protective garment to be worn by the user, a face shield being an integrated part of the head gear of a protective garment, or a removable face panel for insertion into a protective garment, or a protective head gear, or for attaching to a cap or a hat (e.g., with a hook-and-loop fastener such as Velcro).
  • the attachment structure being integral with the substrate which forms the face panel, or a face shield connected to a protective garment to be worn by the user, a face shield being an integrated part of the head gear of a protective garment, or a removable face panel for insertion into a protective garment, or a protective head gear, or for attaching to a cap or a hat (e.g., with a hook-and-loop fastener such as Velcro).
  • Example 1 Tests were conducted to evaluate antimicrobial efficacy & the long- lasting antiviral properties of sulfonated polymers, film samples of sulfonated penta block copolymer (SPBC) of the structure poly[tert-butylstyrene-b-(ethylene-alt-propylene)-b-(styrene- co-styrene ⁇ sulfonate)-b-(ethylene-alt-propylene)-tert-butyl styrene] with 52% sulfonation were cast out of 1 : 1 mixture of toluene and 1 -propanol.
  • SPBC sulfonated penta block copolymer
  • the sulfonated polymer film samples were subjected to abrasion testing of 2200 cycles in the presence of 3 common disinfectants: 1) 70% ethanol, benzalkonium chloride, and quaternary ammonia], and exposure to SARS-CoV-2 virus suspension of concentration 10 7 pfu/ml.
  • DMEM Gibco Dulbecco's Modified Eagle Medium
  • DMEM surface pro Gibco Dulbecco's Modified Eagle Medium
  • Example 2 In this example, a multi-layer laminate is structured by casting a sulfonated block polymer solution (sulfonated block polymers in toluene/ 1 -propanol at a 1 : 1 ratio) onto a Mylar sheet of 1 mil (25.4 pm) thick.
  • a sulfonated block polymer solution sulfonated block polymers in toluene/ 1 -propanol at a 1 : 1 ratio
  • the casting is done on a mechanical casting table with a casting blade, e.g., Elcometer 4340, that controls the thickness, and the speed of solution being casted on a substrate.
  • a casting blade e.g., Elcometer 4340
  • a set amount of sulfonated polymer depending on the desired thickness, is poured onto a substrate.
  • a casting blade is pulled over the liquid, creating a uniform thickness over a substrate.
  • the material is next placed in a chamber where the solvent can be slowly evaporated. After all the solvent is evaporated, the casting is complete forming a laminate structure having thickness ranging from 0.0176 inches(0.044 cm) to 0.0003 inches (0.00076 cm).
  • Example 3 A polyethylene flat sheet of 0.5 mm thick is chlorosulfonated by immersing for six hours at room temperature in a sulfur dioxide/chlorine gas mixture (3:1 volume ratio) in visible light. The chlorosulfonated polyethylene sheet is then immersed in IN NaOH at 50°C. for two days to hydrolyze the pendant sulfonyl chloride groups (— SO2CI) groups to sulfonic groups (— SC>3Na+). The sulfonic acid form is obtained by treating the sheet with IN HC1 at room temperature for four hours. The sheet is then washed with deionized water and dried under vacuum.
  • — SO2CI pendant sulfonyl chloride groups
  • SC>3Na+ sulfonic groups
  • the milli-equivalence (meq) of sulfonic acid groups per gram of polyethylene is determined by titration with NaOH and found to be 1.69 meq/g.
  • the sulfonated polyethylene sheet can be cut into appropriate sizes for the protection of surfaces.
  • Example 4 Diehl oromethane (50 mL, 66 gm) and chlorosulfonic acid (between 0.7 and 1.4 gms) are added sequentially to a wide mouth glass bottle (120 mL capacity, 2 inch diameter). 10 mL of this solution are added to dichloromethane (50 mL, 66 gms) in a wide mouth glass jar (410 mL, 3 inch diameter). To this mixture is added a 1 mil (0.001 inch, 0.0025 cm) colorless PPS (Polyphenylene Sulfide) film. The film is allowed to react for various amounts of time at 25° C. while being suspended in the reaction solution.
  • PPS Polyphenylene Sulfide
  • the black film is then added to distilled water (200 mL) and the film turned light yellow.
  • the film is washed extensively with more water (about 2 liter) and then boiled in water (250 mL) for about 1 hour.
  • the film is then suspended in 1 molar sodium chloride (220 mL) and the amount of sulfonation is determined by titration with 0.01 molar sodium hydroxide to a pH 7 end point.
  • the amount of sulfonation (in meq/g SO 3 H) with reaction-time is 0.64 (1 hour), 1.27 (6.5 hours), 1.71 (16 hours), 1.86 (24 hours), 2.31 (48 hours), and 2.6 (60 hours).
  • the sulfonated poly(phenylene sulfide) film can be used for antimicrobial applications as coating materials or as protective films for use with face shields.
  • the term “comprising” means including elements or steps that are identified following that term, but any such elements or steps are not exhaustive, and an embodiment can include other elements or steps. Although the terms “comprising” and “including” have been used herein to describe various aspects, the terms “consisting essentially of’ and “consisting of’ can be used in place of “comprising” and “including” to provide for more specific aspects of the disclosure and are also disclosed.

Abstract

A face shield (100) includes a transparent face panel (102) configured to extend facing at least a portion of a face of a wearer (200), and has a first surface (136) adapted to be disposed facing the face of the wearer (200) and second surface (138) disposed opposite to the first surface (136). The face panel (102) is protected by a sulfonated polymeric layer (150) on the second surface (138), for killing at least 95% microbes within 30 minutes of contact. The sulfonated polymeric is sufficiently or selectively sulfonated to contain from 10 - 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units, for killing at least 99% of microbes within 5 minutes of coming into contact with the face panel (102).

Description

Self-Disinfecting Face Shield
TECHNICAL FIELD
[001] The disclosure relates to a self-disinfecting face shield, having a protective anti- microbial layer.
BACKGROUND
[002] With the spread of contagious diseases, such as, COVID 19, it becomes necessary to protect people and prevent the people from coming into contact with diseases spreading microbes, e.g., viruses, bacteria, etc. Generally, people use face shields or face masks to prevent inhalation or entry of microbes. However, microbes such as viruses or bacteria would accumulate on an outer surface of the face shield, and may remain active for relatively long duration. These viruses or bacteria may contact the hands of the wearer, when the wearer removes the face shield, and subsequently may find their way inside the human body, which is undesirable.
[003] There is still a need for improved face shields that prevents accumulation of active viruses or bacteria on its surface.
SUMMARY [004] In a first aspect, a self-disinfecting face shield is disclosed. The face shield comprises: a transparent face panel configured to extend facing at least a portion of a face of a wearer, the transparent face panel comprising a substrate having a first surface adapted to be disposed facing the face of the wearer and second surface disposed opposite to the first surface. At least one of first surface and the second surface is protected by a sulfonated polymeric layer for killing at least 90% microbes within 120 minutes of contact with the transparent face panel. The sulfonated polymeric layer comprises, or consists essentially, or consists of a sulfonated polymer, the sulfonated polymer from the group of perfluorosulfonic acid polymers, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyesters, sulfonated polysulfones, sulfonated polyketones, sulfonated poly(arylene ether), and mixtures thereof. The sulfonated polymeric layer has a thickness of at least > 1 pm. [005] In some aspects, the sulfonated polymeric layer comprises at least 50 wt.%, more preferably at least 70 wt.%, even more preferably at least 90 wt.%, yet more preferably at least 95 wt.%, still more preferably at least 98 wt.%, even more preferably at least 99 wt.% and most preferably 100 wt.% (i.e. consists) of one or more of the sulfonated polymers. [006] In some aspects, the sulfonated polymer is a selectively sulfonated negative- charged anionic block copolymer, having at least one alkenyl arene polymer block A and at least one substantially completely, hydrogenated conjugated diene polymer block B, with substantially all of the sulfonic functional groups grafted to alkenyl arene polymer block A for the block A to be a hydrophilic end-block. [007] In some aspects, the sulfonated polymeric layer is applied onto the second surface by dip coating, spray coating, dispersion coating, solvent casting, or adhesively attached to the second surface as a peel-and-stick film.
[008] In some aspects, the face shield further comprises an attachment structure coupled to the face panel and configured to secure the face panel in front of the face of the wearer.
DESCRIPTION OF THE DRAWINGS
[009] FIG. 1 illustrates a sectional view of a face panel of an embodiment of the face shield depicting a first polymeric film attached to a transparent laminate.
[010] FIG. 2 is a perspective view of an embodiment of a face shield.
[011] FIG. 3 is a perspective view of an embodiment of a face shield.
[012] FIG. 4 is a perspective view of an embodiment of a face shield.
[013] FIG. 5 is a perspective view of an embodiment of a face shield.
[014] FIG. 6 is a perspective view of an embodiment of a face shield.
[015] FIG. 7 is a perspective view of an attachment structure of the face shield of FIG.6. [016] FIG. 8 is a perspective view of an embodiment of a face shield.
[017] FIG. 9 is a perspective view of an embodiment of a face shield.
[018] FIG. 10 is a perspective view of an embodiment of a face shield.
[019] FIG. 11 is a perspective view of an embodiment of a face shield. DETAILED DESCRIPTION
[020] The following terms used the specification have the following meanings: [021] “Effective amount” refers to an amount sufficient to alter, destroy, inactivate, and / or neutralize microbes, e.g., an amount sufficient to sterilize and kill microbes in contact with outer surface of the face panel in a face shield.
[022] “Fogging” can be evaluated by directly breathing onto a face shield held approximately one inch from the mouth. Fogging is determined subjectively to be (i) “excellent if no fogging of the film was observed; (ii) fair if fogging is observed but dissipated within 2 seconds; or (iii) poor if fogging persisted more than 2 seconds. If excellent or fair, a coating is said to have anti-fogging properties. Anti-fog property can be expressed by Tf0 , which is the time in minutes it takes to form a fog on a surface, e.g., exposing a layer (surface) to steam from boiling water at a 20 centimeter distance from the water’s surface in an environment of 50% RH (relative humidity) and 22° C. For example, if the surface has a Tf0g of 30 minutes, it means that no fog is formed on a surface of said coating within 30 minutes under the testing conditions described.
[023] “Haze” means the percentage of transmitted light that upon passing through a specimen is scattered greater than 2.5 degrees from the normal. Haze and transmittance can be measured according to ASTM D1003 test method. A higher haze value indicates greater scattering.
[024] “Ion Exchange Capacity” or IEC refers to the total active sites or functional groups responsible for ion exchange in a polymer. Generally, a conventional acid-base titration method is used to determine the IEC, see for example International Journal of Hydrogen Energy, Volume 39, Issue 10, March 26, 2014, Pages 5054-5062, “Determination of the ion exchange capacity of anion-selective membrane.” IEC is the inverse of “equivalent weight” or EW, which the weight of the polymer required to provide 1 mole of exchangeable protons.
[025] “Microbes” refers to microorganisms including bacteria, archaea, fungi (yeasts and molds), algae, protozoa, and viruses, with microscopic size.
[026] “Peel-and-stick” or “peel-and-stick film” refers to a laminate having at least two layers, a release layer or liner which can also be a support layer, and another layer containing the sulfonated polymer. The peel-and-stick is self-adhesive, or releasable or peelable, or removable after being attached to a surface. The release layer is optionally coated with an adhesive which permits it to stick to a surface without glue, paste, or the like, allowing the peel-and-stick to be separable after being applied onto a surface. In embodiments, the layer containing the sulfonated polymer is optionally coated with an adhesive for the layer stick to surface, but is still releasable.
[027] “Releasable” or “separable” bond in the context of layers or surfaces means that the layers or surfaces are generally attached or fastened to each other, yet can be separated with the application of a certain amount of force, and then subsequently refastened or reattached at a later time. In order to be “separable” or “releasable,” the surfaces must be capable of being fastened and separated, and the force applied to separate the layers or surfaces can be applied by hand.
[028] “Surface pH” refers to the pH on the contact surface of the bio-secure material, that results from surface bound moieties e.g., the coating layer. The surface pH can be measured with commercial surface pH measuring instruments, e.g., SenTix™ Sur-electrode from WTW Scientific-Technical Institute GmbH, Weilheim, Germany.
[029] The disclosure relates to a face shield having a protective antimicrobial layer that kills microbes within a predefined duration of contact. The face shield has a transparent panel with its surface (away from the wearer’s face) being coated or protected with a layer comprising a self-sterilizing (self-disinfecting) sulfonated polymeric material. The portion of the face shield directed to the wearer can also be coated or protected with a self-sterilizing material, a sulfonated polymer. In embodiments, the protective material comprises, consists essentially of, or consists of a sulfonated polymer. The sulfonated polymer coats the surface of the transparent face panel for killing at least 95% microbes within a pre-defmed duration of contact. The face shield includes an attachment structure to secure the transparent panel in front of the face of the wearer.
[030] Self-sterilizing Material - Sulfonated Polymer: Sulfonated polymer refers to polymers having a sulfonate group, e.g., — SO3, either in the acid form (e.g., — SO3H, sulfonic acid) or a salt form (e.g., — SCbNa). The term “sulfonated polymer” also covers sulfonate containing polymers, e.g., polystyrene sulfonate.
[031] The sulfonated polymer is selected from the group of perfluorosulfonic acid polymers (e.g., sulfonated tetrafluoroethylene), sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyester, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polysulfones such as polyether sulfone, sulfonated polyketones such as polyether ether ketone, sulfonated polyphenylene ethers, and mixtures thereof. [032] The sulfonated polymer is characterized as being sufficiently or selectively sulfonated to contain from 10 - 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units or the block to be sulfonated (“degree of sulfonation”), to kill at least 95% of microbes within 120 minutes of coming into contact with the coating material. In embodiments, the sulfonated polymer has a degree of sulfonation of > 25 mol %, or > 50 mol %, or < 95 mol %, or 25-70 mol %. Degree of sulfonation can be calculated by NMR or ion exchange capacity (IEC).
[033] In embodiments, the sulfonated polymer is a sulfonated tetrafluoroethylene, having a polytetrafluoroethylene (PTFE) backbone; (2) side chains of vinyl ethers (e.g.,
- O - CF2 - CF - O - CF2 - CF2-) which terminate in sulfonic acid groups in a cluster region.
[034] In embodiments, the sulfonated polymer is a polystyrene sulfonate, examples include potassium polystyrene sulfonate, sodium polystyrene sulfonate, a co-polymer of sodium polystyrene sulfonate and potassium polystyrene sulfonate (e.g., a polystyrene sulfonate copolymer), having a molecular weight of 20,000 to 1,000,000 Daltons, or > 25,000 Daltons, or > 40,000 Dalton, or > 50,000, or > 75,000, or > 100,000 Daltons, or > 400,000 Daltons, or < 200,000, or < 800,000 Daltons, or up to 1,500,000 Daltons. The polystyrene sulfonate polymers can either be crosslinked or uncrosslinked. In embodiments, the polystyrene sulfonate polymers are uncrosslinked and water soluble.
[035] In embodiments, the sulfonated polymer is a polysulfone, selected from the group of aromatic polysulfones, polyphenylenesulfones, aromatic polyether sulfones, dichlorodiphenoxy sulfones, sulfonated substituted polysulfone polymers, and mixtures thereof. In embodiments, the sulfonated polymer is a sulfonated polyethersulfone copolymer, which can be made with reactants including sulfonate salts such as hydroquinone 2-potassium sulfonate (HPS) with other monomers, e.g., bisphenol A and 4-fluorophenyl sulfone. The degree of sulfonation in the polymer can be controlled with the amount of HPS unit in the polymer backbone.
[036] In embodiments, the sulfonated polymer is a sulfonated polyether ketone. In embodiments, the sulfonated polymer is a sulfonated polyether ketone ketone (SPEKK), obtained by sulfonating a polyether ketone ketone (PEKK). The polyether ketone ketone can be manufactured using diphenyl ether and a benzene dicarbonic acid derivative. The sulfonated PEKK can be available as an alcohol and / or water-soluble product, e.g., for subsequent use to coat the face mask or in spray applications.
[037] In embodiments, the sulfonated polymer is a sulfonated poly(arylene ether) copolymer containing pendant sulfonic acid groups. In embodiments, the sulfonated polymer is a sulfonated poly(2,6-dimethyl-l,4-phenylene oxide), commonly referred to as sulfonated polyphenylene oxide. In embodiments, the sulfonated polymer is a sulfonated poly(4- phenoxybenzoyl-1, 4-phenyl ene) (S-PPBP). In embodiments, the sulfonated polymer is a sulfonated polyphenylene having 2 to 6 pendant sulfonic acid groups per polymer repeat, and characterized as having 0.5 meq (SCbHyg of polymer to 5.0 meq (SCbHj/g polymer, or at least 6 meq/g (SCbHj/g polymer.
[038] In embodiments, the sulfonated polymer is a sulfonated polyamide, e.g. aliphatic polyamides such nylon-6 and nylon-6,6, partially aromatic polyamides and polyarylamides such as poly(phenyldiamidoterephthalate), provided with sulfonate groups chemically bonded as amine pendant groups to nitrogen atoms in the polymer backbone. The sulfonated polyamide can have a sulfonation level of 20 to up to 100% of the amide group, with the sulfonation throughout the bulk of the polyamide. In embodiments, the sulfonation is limited to a high density of sulfonate groups at the surface, e.g., > 10%, > 20%, > 30%, or > 40%, or up to 100% of the sulfonated amide group at the surface (within 50 nm of the surface).
[039] In embodiments, the sulfonated polymer is a sulfonated polyolefin, containing at least 0.1 meq, or > 2 meq, or > 3 meq, or > 5 meq, or 0.1 to 6 meq of sulfonic acid per gram of polyolefin. In embodiments, the sulfonated polymer is a sulfonated polyethylene. The sulfonated polyolefin can be formed by chlorosulfonation of a solid polyolefin obtained by polymerization of an olefin or a mixture of olefins selected from a group consisting of ethylene, propylene, butene- 1,4-methylpentene-l, isobutylene, and styrene. The sulfonyl chloride groups can then be hydrolyzed, for example, in an aqueous base such as potassium hydroxide or in a water dimethylsulfoxide (DMF) mixture to form sulfonic acid groups. In embodiment, the sulfonated polyolefin is formed by submerging or passing polyolefin object in any form of powder, fiber, yarn, woven fabric, a film, a preform, etc., through a liquid containing sulfur trioxide (SO3), a sulfur trioxide precursor (e.g., chlorosulfonic acid, HSO3CI), sulfur dioxide (SO2), or a mixture thereof. In other embodiments, the polyolefin object is brought into contact with a sulfonating gas, e.g., SO2 or SO3, or gaseous reactive precursor, or a sulfonation additive that evolves a gas SOx at elevated temperature. [040] The polyolefin precursor to be sulfonated can be, for example, a poly-a-olefm, such as polyethylene, polypropylene, polybutylene, polyisobutylene, ethylene propylene rubber, or a chlorinated polyolefin (e.g., polyvinylchloride, or PVC), or a polydiene, such as polybutadiene (e.g., poly-1, 3-butadiene or poly- 1,2-butadiene), polyisoprene, dicyclopentadiene, ethylidene norbornene, or vinyl norbornene, or a homogeneous or heterogeneous composite thereof, or a copolymer thereof (e.g., EPDM rubber, i.e., ethylene propylene diene monomer). In embodiments, the polyolefin is selected from low density polyethylene (LDPE), linear low density polyethylene (LLDPE), very low density polyethylene (VLDPE), high density polyethylene (HDPE), medium density polyethylene (MDPE), high molecular weight polyethylene (HMWPE), and ultra-high molecular weight polyethylene (UHMWPE).
[041] In embodiments, the sulfonated polymer is a sulfonated polyimide, e.g., aromatic polyimides in both thermoplastic and thermosetting forms, having excellent chemical stability and high modulus properties. Sulfonated polyimide can be prepared by condensation polymerization of dianhydrides with diamines, wherein one of the monomeric units contains sulfonic acid, sulfonic acid salt, or sulfonic ester group. The polymer can also be prepared by direct sulfonation of aromatic polyimide precursors, using sulfonation agents such as chlorosulfonic acid, sulfur trioxide and sulfur trioxide complexes. In embodiments, the concentration of sulfonic acid groups in the sulfonated polyimide as measured by ion exchange capacity, IEC, varying from 0.1 meq/g to above 3 meq/g, or at least 6 meq/g.
[042] In embodiments, the sulfonated polymer is a sulfonated polyester, formed by directly sulfonating a polyester resin in any form, e.g., fiber, yarn, woven fabric, film, sheet, and the like, with a sulfuric anhydride-containing gas containing sulfuric anhydride, for a concentration of the sulfone group on the surface of the polyester ranging from 0.1 meq/g to above 3 meq/g, e.g., up to 5 meq/g, or at least 6 meq/g.
[043] In embodiments, the sulfonated polymer is a selectively sulfonated negative- charged anionic block copolymer. The term “selectively sulfonated” definition to include sulfonic acid as well as neutralized sulfonate derivatives. The sulfonate group can be in the form of metal salt, ammonium salt or amine salt.
[044] Depending on the applications and the desired properties, the sulfonated polymer can be modified (or funcationalized). In embodiments, the sulfonated polymer is neutralized with any of various metal counterions, including alkali, alkaline earth, and transition metals, with at least 10% of the sulfonic acid groups being neutralized. In embodiments, the sulfonated polymer is neutralized with inorganic or organic cationic salts, e.g, those based on ammonium, phosphonium, pyridinium, sulfonium and the like. Salts can be monomeric, oligomeric, or polymeric. In embodiments, the sulfonated polymer is neutralized with various primary, secondary, or tertiary amine-containing molecules, with > 10% of the sulfonic acid or sulfonate functional groups being neutralized.
[045] In embodiments, the sulfonic acid or sulfonate functional group is modified by reaction with an effective amount of polyoxyalkyleneamine having molecular weights from 140 to 10,000. Amine-containing neutralizing agents can be mono-functional or multi-functional; monomeric, oligomeric, or polymeric. In alternative embodiments, the sulfonated polymer is modified with alternative anionic functionalities, such as phosphonic acid or acrylic and alkyl acrylic acids.
[046] In embodiments, amine containing polymers are used for the modification of the sulfonated polymers, forming members of a class of materials termed coaservates. In examples, the neutralizing agent is a polymeric amine, e.g., polymers containing benzylamine functionality. Examples include homopolymers and copolymers of 4-dimethylaminostyrene which has been described in US Patent 9,849,450, incorporated herein by reference. In embodiments, the neutralizing agents are selected from polymers containing vinylbenzylamine functionality, e.g., polymers synthesized from poly-p-methyl styrene containing block copolymers via a bromination-amination strategy, or by direct anionic polymerization of amine containing styrenic monomers. Examples of amine functionalities for functionalization include but are not limited to p - vinylbenzyldimethylamine (BDMA ), p - vinylbenzylpyrrolidine (VBPyr ), p - vinylbenzyl- bis(2-methoxyethyl)amine (VBDEM ), p-vinylbenzylpiperazine (VBMPip ), and p- vinylbenzyldiphenylamine (VBDPA). In embodiments, corresponding phosphorus containing polymers can also be used for the functionalization of the sulfonated polymers.
[047] In embodiments, the monomer or the block containing amine functionality or phosphine functionality can be neutralized with acids or proton donors, creating quaternary ammonium or phosphonium salts. In other embodiments, the sulfonated polymer containing tertiary amine is reacted with alkylhalides to form functional groups, e.g., quatemized salts. In some embodiments, the sulfonated polymer can contain both cationic and anionic functionality to form so-called zwitterionic polymers. [048] In some embodiments, the sulfonated polymer is a selectively sulfonated negative-charged anionic block copolymer, which “selectively sulfonated” definition to include sulfonic acid as well as neutralized sulfonate derivatives. The sulfonate group can be in the form of metal salt, ammonium salt or amine salt. In embodiments, the sulfonated block polymer has a general configuration A-B-A, (A-B)n(A), (A-B-A)n, (A-B-A)nX, (A-B)nX, A-D-B, A-B-D, A-D- B-D-A, A-B-D-B-A, (A-D-B)nA, (A-B-D)nA (A-D-B )nX, (A-B-D)nX or mixtures thereof; where n is an integer from 0 to 30, or 2 to 20 in embodiments; and X is a coupling agent residue. Each A and D block is a polymer block resistant to sulfonation. Each B block is susceptible to sulfonation. For configurations with multiple A, B or D blocks, the plurality of A blocks, B blocks, or D blocks can be the same or different.
[049] In embodiments, the A blocks are one or more segments selected from polymerized (i) para-substituted styrene monomers, (ii) ethylene, (iii) alpha olefins of 3 to 18 carbon atoms; (iv) 1,3 -cyclodiene monomers, (v) monomers of conjugated dienes having a vinyl content less than 35 mol percent prior to hydrogenation, (vi) acrylic esters, (vii) methacrylic esters, and (viii) mixtures thereof. If the A segments are polymers of 1,3 -cyclodiene or conjugated dienes, the segments will be hydrogenated subsequent to polymerization of the block copolymer and before sulfonation of the block copolymer. The A blocks may also contain up to 15 mol % of the vinyl aromatic monomers such as those present in the B blocks.
[050] In embodiments, the A block is selected from para-substituted styrene monomers selected from para-methylstyrene, para-ethyl styrene, para-n-propyl styrene, para-iso- propyl styrene, para-n -butyl styrene, para-sec-butyl styrene, para-iso-butyl styrene, para-t- butylstyrene, isomers of para-decyl styrene, isomers of para-dodecyl styrene and mixtures of the above monomers. Examples of para-substituted styrene monomers include para-t-butyl styrene and para-methylstyrene, with para-t-butyl styrene being most preferred. Monomers may be mixtures of monomers, depending on the particular source. In embodiments, the overall purity of the para-substituted styrene monomers be at least 90%-wt., or > 95%-wt., or > 98%-wt. of the para-substituted styrene monomer.
[051] In embodiments, the block B comprises segments of one or more polymerized vinyl aromatic monomers selected from unsubstituted styrene monomer, ortho- substituted styrene monomers, meta- substituted styrene monomers, alpha-methylstyrene monomer, 1,1- diphenyl ethylene monomer, 1,2-diphenyl ethylene monomer, and mixtures thereof. In addition to the monomers and polymers noted, in embodiments the B blocks also comprises a hydrogenated copolymer of such monomer (s) with a conjugated diene selected from 1,3 -butadiene, isoprene and mixtures thereof, having a vinyl content of between 20 and 80 mol percent. These copolymers with hydrogenated dienes can be any of random copolymers, tapered copolymers, block copolymers or controlled distribution copolymers. The block B is selectively sulfonated, containing from about 10 to about 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units. In embodiments, the degree of sulfonation in the B block ranges from 10 to 95 mol%, or 15 - 80 mol%, or 20 - 70 mol%, or 25 - 60 mol%, or > 20 mol%, or > 50 mol%. [052] The D block comprises a hydrogenated polymer or copolymer of a conjugated diene selected from isoprene, 1,3 -butadiene and mixtures thereof. In other examples, the D block is any of an acrylate, a silicone polymer, or a polymer of isobutylene with a number average molecular weight of > 1000, or >2000, or >4000, or >6000.
[053] The coupling agent X is selected from coupling agents known in the art, including polyalkenyl coupling agents, dihaloalkanes, silicon halides, siloxanes, multifunctional epoxides, silica compounds, esters of monohydric alcohols with carboxylic acids, (e.g. methylbenzoate and dimethyl adipate) and epoxidized oils.
[054] The antimicrobial and mechanical properties of the sulfonated block copolymer can be varied and controlled by varying the amount of sulfonation, the degree of neutralization of the sulfonic acid groups to the sulfonated salts, as well as controlling the location of the sulfonated group(s) in the polymer. In embodiments and depending on the applications, e.g., one with the need for water dispersity / solubility, or at the other spectrum, one with the need for sufficient durability with constant wiping with water based cleaners, the sulfonated block copolymer can be selectively sulfonated for desired water dispersity properties or mechanical properties, e.g., having the sulfonic acid functional groups attached to the inner blocks or middle blocks, or in the outer blocks of a sulfonated block copolymer, as in US Patent No. US8084546, incorporated by reference. If the outer (hard) blocks are sulfonated, upon exposure to water, hydration of the hard domains may result in plasticization of those domains and softening, allowing dispersion or solubility. [055] The sulfonated copolymer in embodiments is as disclosed in Patent Publication
Nos. US9861941, US8263713, US8445631, US8012539, US8377514, US8377515, US7737224, US8383735, US7919565, US8003733, US8058353, US7981970, US8329827, US8084546, US8383735, US10202494, and US10228168, the relevant portions are incorporated herein by reference.
[056] In embodiments, the sulfonated block copolymer has a general configuration A- B-(B-A)I-5, wherein each A is a non-elastomeric sulfonated monovinyl arene polymer block and each B is a substantially saturated elastomeric alpha-olefin polymer block, said block copolymer being sulfonated to an extent sufficient to provide at least 1% by weight of sulfur in the total polymer and up to one sulfonated constituent for each monovinyl arene unit. The sulfonated polymer can be used in the form of their acid, alkali metal salt, ammonium salt or amine salt.
[057] In embodiments, the sulfonated block copolymer is a sulfonated polystyrene- polyisoprene-polystyrene, sulfonated in the center segment. In embodiments, the sulfonated block copolymer is a sulfonated t-butyl styrene / isoprene random copolymer with C=C sites in their backbone. In embodiments, the sulfonated polymer is a sulfonated SBR (styrene butadiene rubber) as disclosed in US 6,110,616 incorporated by reference. In embodiments, the sulfonated polymer is a water dispersible BAB triblock, with B being a hydrophobic block such as alkyl or (if it is sulfonated, it becomes hydrophilic) poly(t-butyl styrene) and A being a hydrophilic block such as sulfonated poly(vinyl toluene) as disclosed in US 4,505,827 incorporated by reference.
In embodiments, the sulfonated block copolymer is a functionalized, selectively hydrogenated block copolymer having at least one alkenyl arene polymer block A and at least one substantially completely, hydrogenated conjugated diene polymer block B, with substantially all of the sulfonic functional groups grafted to alkenyl arene polymer block A (as disclosed in US 5516831, incorporated by reference). In embodiments, the sulfonated polymer is a water- soluble polymer, a sulfonated diblock polymer of t-butyl styrene / styrene, or a sulfonated triblock polymer of t-butyl styrene -styrene - t-butyl styrene as disclosed in US 4,492,785 incorporated by reference. In embodiments, the sulfonated block copolymer is a partially hydrogenated block copolymer.
[058] In embodiments, the sulfonated polymer is a midblock-sulfonated triblock copolymer, or a midblock-sulfonated pentablock copolymer or, e.g., a poly(p-tert-butylstyrene-b- styrenesulfonate -b-p-tert-butylstyrene), or a poly[tert-butylstyrene-b-(ethylene-alt-propylene)-b- (styrenesulfonate)-b-(ethylene-alt-propylene)-b-tert-butylstyrene. [001] In embodiments, the sulfonated polymer contains > 15 mol %, or > 25 mol %, or > 30 mol %, or > 40 mol %, or > 60 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units in the polymer that are available or susceptible for sulfonation, e.g., the styrene monomers.
[002] In embodiments, the sulfonated polymer has an ion exchange capacity of > 0.5 meq/g, or > 0.75 meq/g, or > 1.0 meq/g, or > 1.5 meq/g, or > 2.0 meq/g, or > 2.5 meq/g, or < 5.0 meq/g.
[003] Optional Additives: In embodiments, the sulfonated polymer further contains or can be complexed with, or otherwise form mixtures, compounds, etc. with, antibiotics such as butylparaben and triclosan, e.g., antimicrobial surfactants, lipids, nanoparticles, peptides, antibiotics or antiviral drugs, quaternary ammonium and phosphonium containing polymers, chitosan and other naturally occurring antimicrobial polymers, ion-exchange resins, metallic- based micro and nano- structured materials such as silver, copper, zinc and titanium and their oxides, for enhanced antimicrobial effectiveness.
[059] In embodiments, the sulfonated polymer further comprises additives for decorative or safety effects, e.g., luminescent additives such as phosphorescent and fluorescence that would help or enable the sulfonated polymer layer to illuminate.
[060] In embodiments, the optional additives are optical brighteners additives that illuminate under a special UV or black light tracer, allowing for physical inspections to verify that intended surfaces are coated or have remained intact, offering the intended antimicrobial / self-disinfecting effects.
[061] In embodiments, the optical additives are UV stabilizers, e.g., UV absorbers, quenchers known in the art.
[062] In embodiments, the sulfonated polymer further comprises additives that would help signal or give an indicator of its antimicrobial effects with a color change pH indicator. Examples include Thymol Blue, Methyl Orange, Bromocresol Green, Methyl Red, Bromothymol Blue, Phenol Red, and Phenol-phthalein. A color change means a change in hue, from a light to a darker color or vice versa. A color indicator may indicate if a recharge, regeneration, or reactivation of the antimicrobial activity of the protective layer is recommended. The color indicator is incorporated in a sufficient amount so that a noticeable change in color hue is observed immediately when there is a change in the effectiveness of the sulfonated polymeric material, e.g., when its surface pH is increased above 2.0. In embodiments, the amount of color indicator ranges from 0.1 to 20 wt.% of the amount of sulfonated polymer applied as a protective layer on the frequently-touched surface.
[063] In addition to the above optional components, other additives such as plasticizers, tackifiers, surfactants, film forming additives, dyes, pigments, cross-linkers, UV absorbers, catalysts, highly conjugated particles, sheets, or tubes (e.g. carbon black, graphene, carbon nanotubes), etc. may be incorporated in any combination to the extent that they do not reduce the efficacy of the material.
[064] Properties of Sulfonated Polymer: When applied as a thin protective layer, the sulfonated polymer is characterized as being transparent. Transparency refers to optical clarity, meaning that enough light is transmitted through to allow visualization through the film by an observer. Although some haze or coloration may be presented, such haze or coloration does not substantially interfere with visualization. In embodiments, an antimicrobial sulfonated polymeric layer has a transmission rate of at least 90%, or at least 91%; or clarity of at least 99% or 99.5%; or a haze value of < 1.5%, or < 1.25%, or < 1.0%, or < 0.75%. Haze can be measured according to ASTM D-1003. This is in comparison with clear acrylic layers having transmission of 94.5%, haze of 0.1, and clarity of 100%.
[065] In embodiments, the sulfonated polymer is characterized as having anti-fogging properties, with a Tf0 of > 5 minutes , i.e., no fog is formed on a surface of substrates having sulfonated polymer coating within about 5 minutes. In embodiments, the Tf0g is > 15 minutes, or > 30 minutes.
[066] In embodiments, the sulfonated polymer is characterized as being sufficiently sulfonated to have an IEC of > 0.5 meq/g, or 1.5 - 3.5 meq/g, or > 1.25 meq/g, or > 2.2 meq/g, or > 2.5 meq/g, or > 4.0 meq/g, or < 4.0 meq/g.
[067] In embodiments, the sulfonated polymer is characterized as having a surface pH of < 3.0, or < 2.5, or < 2.25, or < 2.0, or < 1.80. It is believed that a sufficiently low surface level, as a result of the presence of sulfonic acid functional groups in the protective layer, would have catastrophic effects on microbes that come in contact with the surface.
[068] In embodiments, the sulfonated polymer works effectively in destroying / inactivating at least 99%, or at least 99.5%, or at least 99.9% of microbes in < 30 minutes of exposure, or < 5 minutes of exposure or contact with microbes, including but not limited to MRSA, vancomycin-resistant Enterococcus faecium, X-MulV, PI-3, SARS-CoV-2, carbapenem- resistant Acinetobacter baumannii, and influenza A virus. In embodiments with polymer containing quaternary ammonium group, the material is effective in killing target microbes including Staphylococcus aureus, Escherichia coli, Staphylococcus albus, Escherichia coli, Rhizoctonia solani, and Fusarium oxysporum. The sulfonated polymer remains effective in killing microbes even after 4 hours, or after 12 hours, or at least 24 hours, or for at least 48 hours.
[069] In embodiments, the sulfonated polymer is a sulfonated block copolymer, e.g., a midblock-sulfonated pentablock copolymer, containing > 40 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units. In tests simulating cleaning of the surface of a sulfonated polymeric film, after 2400 cleaning or abrasion cycle, representing 200 days (at least 6 months) in use with 6 cleaning sessions per day (with 4 rubbing motions per session with alcohol and / or quaternary ammonium compounds cleaners).
[070] Methods for Applying Protective Laver on Face Shield: The sulfonated polymer can be applied as a protective coating on the transparent panel of the face shield as a coating, or as a self-adhesive protective film. The sulfonated polymer can be applied onto the substrate before or after it is made into a face panel, and before or after the face panel is incorporated into the face shield, for a protective layer having a thickness of < 1000 pm, or > 1 pm, or > 5 pm, or > 10 pm, or < 500 pm, or < 200 pm, or < 100 pm, or 1 to 1000 pm, or 1 to 500 pm, or 1 to 200 pm, or 1 to 100 pm for a self-sterilizing surface.
[071] The base or substrate (forming the face panel) is formed from a variety of materials. Examples include, but are not limited to, polyesters, such as polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polycarbonates, allyl diglycolcarbonates, polyacrylates, such as polymethyl methacrylate, polystyrenes, cellulose acetate butyrate, glass, and combinations thereof. The substrate can be any of a film, sheet, panel or pane of material, formed by known processes, such as blowing, casting, extrusion, injection molding, etc. The thickness of the substrate is such that it is stiff enough to prevent collapse, yet flexible enough to bend, e.g., from 0.001 to 2 mm, or 0.01 to 0.5 mm, or 0.1 - 0.4 mm, or < 0.5 mm, or at least 0.05 mm.
[072] In embodiments, the sulfonated polymer material is dispersed in a solvent in an amount up to 10 wt.%, or up to 20 wt. %, or up to 50 wt. %, for coating the base substrate as a protective layer. Depending on the sulfonated polymer used, exemplary solvents include but are not limited to water, isopropyl alcohol, acetone, N,N-dimethylacetamide, l-methyl-2- pyrrolidinone, 1,3-dioxolane, 2-methoxy ethanol, dimethylformamide, or benzyl alcohol. In embodiments, the sulfonated polymer is applied by preparing a solution of the polymer in a suitable solvent, then casting on the substrate to be subsequently formed into face panels, with the thickness of the protective polymeric layer being adjusted with a casting knife, followed by drying.
[073] In embodiments, the protective sulfonated polymeric layer is formed on the face panel by methods including but not limited to spray coating, or dip coating the substrate into a solution or dispersion containing the sulfonated polymer. Multiple coatings can be applied sequentially. The face panels can be coated with the sulfonated polymeric material as individual pieces, or they can be formed from a large piece of coated substrate, cut into shapes forming face panels.
[074] In embodiments, the sulfonated polymeric layer is applied on the face panel as a peel-and-stick film. The peel-and-stick film is first peeled off to remove an optional support / release liner if present, and then applied directly onto the base substrate as a protective layer. After the film is positioned on the face panel, a squeegee or slight tap of finger may be used to remove trapped air between the film and the face panel. After a period of time of use as a protective layer cover for the face panel, the releasable peel-and-stick with the sulfonated polymeric protective layer can be peeled off, and replaced with a new peel-and-stick film for protection.
[075] In embodiments with the use of sulfonated polymeric material with anti-fogging properties (e.g., having Tf0 of > 15, or > 30 minutes), the sulfonated polymeric material is used to coat both the outer surface of the transparent face panel microbes upon contact, as well as in the inner surface which facing the wearer to minimize fog formation for extent wearing. [076] Reference will be made to the figures, showing various embodiments of the face shields, with different embodiments of attachment structures.
[077] FIG. 1 illustrates an embodiment of a sectional construction of a face panel, with a protective antimicrobial polymer layer on a transparent substrate. In this embodiment, the face panel 102 has the antimicrobial polymer as a protective layer on both surfaces. As shown, transparent substrate 140 has a first surface 142 (i.e. inner surface 142) adapted to be disposed facing a wearer (not shown) and a second surface 144 (i.e. outer surface 144) disposed opposite to the inner surface 142. The sulfonated polymer is used to coat or applied onto both surfaces as first polymeric film 150 and second polymeric film 152. The polymer film can be applied as a separate layer (e.g., by casting) or by coating both the first and second surfaces of the substrate 140, forming a laminate structure. The first polymeric film 150 defines an outer surface 138 of the face panel 102, being exposed to microbes such as virus or bacteria. The second polymeric film 152 is applied as engaged and abutted with the inner surface 142 of the substrate 140, and thereby defining the inner surface 136 facing the wearer of the face shield.
[078] The first and second polymeric films can be the same or different sulfonated polymers. In embodiments, the second polymeric film 152 comprises a sulfonated block copolymer material from Kraton Corporation with anti-fogging properties, allowing the wearer to better see through the face panel 102. In embodiments, additional “fresh” or new layers of sulfonated polymeric film can be applied onto the first polymeric film as time goes on, for the face shield to continue functioning as a self-sterilizing protective gear.
[079] FIG. 2 illustrates an embodiment of a face shield 100. The face shield 100 includes a transparent face panel 102 adapted to be arranged in front of the face of a wearer 200 (not shown). The face panel 102 can be flat, or substantially arcuate in shape, with a top edge 104, a bottom edge 106 disposed opposite to the top edge 104, a first side edge 108, and a second side edge 110. The top edge 104 may be disposed proximate to forehead of wearer 200, while the bottom edge 106 is disposed distally from the forehead of wearer 200, when the face shield 100 is secured to the wearer 200. Accordingly, the bottom edge 106 may be disposed proximate to chin of the wearer relative to the top edge 104. The first side edge 108 and the second side edge 110 extend from the top edge 104 to the bottom edge 106, and are disposed opposite to each other.
[080] Face shield 100 may include an attachment structure 120 for securing the face panel 102 to the wearer 200, is adapted to position the face panel 120 in front of the face of wearer 200. The attachment structure 120 is adapted to secure the face shield 100 to the wearer’s head, and includes a first strap 122 connected to the face panel 102 at a location proximate to the first side edge 108 and the top edge 102, and a second strap 124 connected to the face panel 102 at allocation proximate to the second side edge 110 and the top edge 102. The attachment structure 120 includes a coupler 126 for attaching the first strap 122 to the second strap 124. [081] In an embodiment, the coupler 126 may include a male member 128 attached to the first strap 122 and a female member 130 attached to the second strap 124 and adapted to removably engage with the male member 128. In some embodiments (not shown), the coupler 120 may be a hook and loop assembly having a hook member attached to the first strap 122 and a loop member attached to the second strap 124. In an embodiment (not shown), the first strap 122 and the second strap 124 may be adhesively attached to an inner surface 136 of the face panel 102. In some embodiments (not shown), the face panel 102 may include cut-outs extending from the inner surface 136 to the outer surface and arranged proximate to the side edges 108, 110, and the straps 122, 124 may be attached to the face panel 102 by inserting a portion of each of the straps 122, 124 through respective cut-outs and then making a knot. It may be appreciated that the straps 122, 124 may be attached to the face panel 102 by any mechanism or methods known in the art.
[082] In embodiments (not shown), the attachment structure 120 may be a simple elastic strap with one end attached or tied to or near the top of the first side edge 108, and with the other end being attached or tied to or near the top of the second side edge 110.
[083] In some embodiments (not shown), the face panel 102 may be built-in as part of a protective garment, such as, personal protective equipment.
[084] FIG. 3 illustrates an alternative embodiment of a face shield 300. The face shield 300 is similar to the face shield 100, with the difference in the attachment structure 302 and in a foam member 306. It may be appreciated that the similar components of the face shields 100,
300 are represented by identical reference numerals. The attachment structure 302 is an elastic band 304 connected to the face panel 102 of the face shield 300 and is adapted to secure the face shield 300 to the head of the wearer 200, for the face panel 102 to be in front of the face of the wearer. Foam member 306 is attached to an inner surface 136 of the face panel 102 and arranged proximate to a top edge 104 of the face panel 102. The foam member 306 provides a cushioning effect to the forehead of wearer 200 and can be removable.
[085] FIG. 4 illustrates yet another alternative embodiment of a face shield 400, which is similar to the face shield 100, and with a different attachment structure 402. Similar components of the face shields 100, 300, and 400 are represented by identical reference numerals. The attachment structure 402 includes a first strap 404 attached to a face panel 102 of the face shield 400, and extending outwardly from a first side edge 108, a second strap 406 attached to the face panel 102 and extending outwardly from the second side edge 110. Coupler 408 is for for attaching the first strap 404 and the second strap 406. The coupler 408 may be a buckle ring 410 attached to the first strap 404, adapted to be removably engaged with the second strap 406. The buckle ring 410 may be attached to the first strap 404 by stitching, or by Velcro (not shown). The second strap 406 is attached to the buckle ring 410 by inserting a portion of the second strap 406 inside the buckle ring 410 as known in the art. In some embodiments, the first strap 404 and the second strap 406 are integrally formed with each other and a portion of the strap is adhesively attached to the inner surface 136 of the face panel 102 (or by Velcro), and extend in an arcuate manner from the first side edge 108 to the second side edge 110.
[086] FIG. 5 illustrates yet another embodiment of a face shield 500, with a different attachment structure 502. Attachment structure 502 may be a frame 504 of an eyeglass attached to a face panel 506 of the face shield 500. The face panel 506 is similar to the face panel 102 of the face shield 100 in function, with a transparent laminate. The frame 504 includes two temples or arms 508, 510 arranged spaced apart from each other and extending outwardly of side edges 512, 514 of the face panel 506. The first temple 508 extends from a first side edge 512, while the second temple 510 extends outwardly of a second side edge 514. Frame 504 includes a bridge 520 adapted to be supported on a nose of the wearer 200, and nose pads 522, 524 secured under the bridge 520. The nose pads 522, 524 are adapted to abut the nose of the wearer 200 and helps keep the frame 504, and hence the face panel 506, in place, while providing comfort and a snug fit.
[087] The frame 504 includes a first arc portion 530 extending from the bridge 520 to the first temple 508, and a second arc portion 532 extending from the bridge 520 to the second temple 510. The face panel 506 may be attached to the two arc portions 530, 532 such that the bridge 520, the nose pads 522, 524, and the arc portions 530, 532 are arranged between the face of the wearer 200 (not shown) and the face panel 506. The two temples 508, 510 are adapted to rest on the ears of the wearer 200 to secure the face shield on the wearer 200. The one or more or the bridge 520, the nose pads 522, 524, and the arc portions 530, 532 may abut the inner surface of the face panel 506, and may be engaged/attached with the face panel 506. In an embodiment, the frame 504 and the face panel 506 may be integrally formed. Alternatively, the face panel 506 may be removably engaged with the frame 504. Additionally, or optionally, the face shield 500 may include cushion pads (not shown) engaged with any of the arc portions 530, 532 and the bridge 520, and are adapted to contact the periphery of the eyes and the nose of the wearer 200 to provide cushioning effect.
[088] FIG. 6 illustrates another embodiment of a face shield 600, with a face panel 602 attached to, or can be removably engaged with eyeglasses 604 via rim portions 630 and 632. Face panel 602 is similar to the face panel in other embodiments. FIG. 7 illustrates an embodiment of protective eyeglasses 604 that can be used with a detachable face panel (not shown).
[089] The eyeglasses include two temples or arms 608, 610 (not shown in FIG. 6) arranged spaced apart from each other and adapted to rest on the ears of the wearer 200, and a bridge 620 adapted to be supported on a nose of the wearer 200 (not shown). Eyeglass 604 may include a first rim portion 630 extending from the bridge 620 to the first temple 608, and a second rim portion 632 extending from the bridge 620 to the second temple 610. To facilitate the removable engagement of the face panel 602, the eyeglass 604 may include a plurality of clips 640 (as shown in FIG. 7). The face panel 602 may arranged between the rim portions 630, 632 and the cushion pad 638. In one embodiment, the face panel 602 (not shown) may be integrally formed with the rim portions 630 and 632
[090] Optionally, the eyeglass 604 may include a cushion pad 638 engaged with the rim portions 630, 632 and the bridge 620 and is adapted to contact, or seal around the periphery of the eyes and the nose of the wearer 200 to provide cushioning effect. It should be noted that the lenses 634 and 636 can also be protected or coated with a layer of the sulfonated polymer.
[091] FIG. 8 illustrates yet another a face shield 800, with components similar to the face shield 100 in FIG. 1 being represented by identical reference numerals. Structure 802 includes a first arm 804 and second arm 806 arranged spaced apart and opposite to first arm 804, facilitating the securing of the face shield 800 to a wearer head (not shown). The first arm 804 extends outwardly from a first side edge 108 and adapted to arranged substantially along a first side, for example, right side of the head and above the right shoulder. Similarly, the second arm 806 extends outwardly from a second side edge 110 and adapted to arranged substantially along a second side, for example, left side of the head and above the left shoulder. Each arm 804, 806 may include an engagement structure, e.g., first engagement structure 808, such as, at least one first cut-out 810, and a second engagement structure 812, such as, at least one second cut-out 814, which can be adapted to engage with a drawstring or an ear loop, facilitating the secure of the face shield 800 to a wearer.
[092] In embodiments (not shown), the face panel 102 includes a nose cavity and / or a cushion for the face panel to rest upon the nose of the wearer. In yet other embodiments (not shown), the first and second arms are shaped such that they fit around the ear lobes of the wearer, keeping the face shield secure for protecting the wearer’s face.
[093] FIG. 9 illustrates yet another embodiment of a face shield 900, with a different attachment structure 902 from the attachment structure 120 in FIG. 1. The attachment structure 902 includes a first arm 904 and second arm (not shown) arranged spaced apart and opposite to the first arm 902, facilitating the securing of the face shield 900 to the wearer’s head. The first arm 902 extends outwardly from a first side edge 908 of a face panel 906 of the face shield 900 and adapted to arranged substantially along a first side, for example, a right side of the head and above the right shoulder. The second arm (not shown) extends outwardly from a second side edge of the face panel 906 and adapted to arranged substantially along a second side, for example, a left side of the head and above the left shoulder. Each of the arms may include an engagement structure, for example, the first arm 902 includes an engagement structure 910, such as, a hole 912, to facilitate a securing of the face panel 906 in front of the face of the wearer 200.
[094] Attachment structure 902 includes a cap 920 adapted to be arranged over the head of the wearer 200, and may include a retention structures, for example, a first retention structure 922 and a second retention structure (not shown) adapted to engage with the engagement structures of the first arm 902 and the second arm. Retention structure 922 may be protrusion 924 extending outwardly from the cap 920. First arm 902 and the second arm may be engaged with the cap 920, such that the protrusions 924 extend through the respective hole 912, for the face panel 906 to be supported on the respective protrusions 924 such that the face panel 906 can be pivoted relative to the cap 920 between a first position (e.g. upward position) and a second position (e.g. downward position). The face panel 906 is formed or contoured corresponding to a profile of the face of the wearer 200.
[095] In embodiments (not shown), the face panel of the face shield covers only the nose and mouth. The face shield has two adjustable arms or temples, as similar to eye glasses, that wrap around a wearer’s ears. [096] FIG. 10 illustrates yet another face shield 1000, which includes a face panel 1002, a frame 1004 supporting the face panel 1002, and extending along the edges of the face panel 1002. The face shield includes a cap (helmet or hat) 1006 adapted to be disposed on a head of the wearer (not shown) and pivotally coupled to the frame 1004. The frame 1004 and the cap 1006 together define as attachment structure 1008 that secure the face shield 1000 to the wearer such that the face panel 1002 is arranged in front of the face of the wearer.
[097] FIG. 11 illustrates another face shield embodiment 1100. Face shield 1100 is adapted to cover only a portion of a face of a wearer (not shown). The face shield 1100 includes a face panel 1102, and a frame 1104 supporting the face panel 1102 and extending along the edges of the face panel 1102 such that the frame 1104 surrounds the face panel 1102. The face panel 1102 with a transparent laminate coated with the sulfonated polymeric layeris adapted to be disposed in front of the eyes of the wearer, therefore may act as protective eyeglasses as well. As shown, frame 1104 may include a nose portion 1106 defining a nose cavity resting on the nose bridge of the wearer, when the face panel 1102 is secured on the face of the wearer 200. Frame 1104 includes a top member 1108 adapted to extend along a forehead of the wearer 200, and two side members 1110, 1112 extending downwardly from the top member 1108. Face shield 1100 may include a pad 1114 attached to the top member and adapted to abut the forehead of the wearer 200. The pad 1114 may include a rubber based material providing a cushioning effect.
[098] The patentable scope is defined by the claims, which include other examples that occur to those skilled in the art and may not have been illustrated by the Figures, e.g., a face shield with a removable transparent face panel, which can be removed and replaced with another face panel, or face shield that can be clipped onto an eyeglass frame, or a face shield having hook-and4oop fastener assembly (e.g., Velcro) straps for use as an attachment structure for the face shield. The face shield can also be one-piece with the attachment structure being integral with the substrate which forms the face panel, or a face shield connected to a protective garment to be worn by the user, a face shield being an integrated part of the head gear of a protective garment, or a removable face panel for insertion into a protective garment, or a protective head gear, or for attaching to a cap or a hat (e.g., with a hook-and-loop fastener such as Velcro).
[099] Example 1 : Tests were conducted to evaluate antimicrobial efficacy & the long- lasting antiviral properties of sulfonated polymers, film samples of sulfonated penta block copolymer (SPBC) of the structure poly[tert-butylstyrene-b-(ethylene-alt-propylene)-b-(styrene- co-styrene^sulfonate)-b-(ethylene-alt-propylene)-tert-butyl styrene] with 52% sulfonation were cast out of 1 : 1 mixture of toluene and 1 -propanol. The sulfonated polymer film samples were subjected to abrasion testing of 2200 cycles in the presence of 3 common disinfectants: 1) 70% ethanol, benzalkonium chloride, and quaternary ammonia], and exposure to SARS-CoV-2 virus suspension of concentration 107 pfu/ml.
[0100] After 2 hours of contact, viable virus was recovered from each sample by washing twice with 500pl of DMEM tissue culture media containing 10% serum, and measured by serial dilution plaque assay. Gibco Dulbecco's Modified Eagle Medium (DMEM) is a basal medium for supporting the growth of many different mammalian cells. The results demonstrate that, after abrasion testing representing approximately one year of cleaning (6 disinfectant wipes/day), surface pro Gibco Dulbecco's Modified Eagle Medium (DMEM) is a widely used basal medium for supporting the growth of many different mammalian cells
[0101] Example 2: In this example, a multi-layer laminate is structured by casting a sulfonated block polymer solution (sulfonated block polymers in toluene/ 1 -propanol at a 1 : 1 ratio) onto a Mylar sheet of 1 mil (25.4 pm) thick.
[0102] The casting is done on a mechanical casting table with a casting blade, e.g., Elcometer 4340, that controls the thickness, and the speed of solution being casted on a substrate. A set amount of sulfonated polymer, depending on the desired thickness, is poured onto a substrate. A casting blade is pulled over the liquid, creating a uniform thickness over a substrate. The material is next placed in a chamber where the solvent can be slowly evaporated. After all the solvent is evaporated, the casting is complete forming a laminate structure having thickness ranging from 0.0176 inches(0.044 cm) to 0.0003 inches (0.00076 cm).
[0103] Surface pH of the antimicrobial layer is measured using a surface pH measuring probe (EDT DirectlON Limited model E8087). For the pH test, a small drop of water around 0.02ml of water is placed on the antimicrobial layer. The probe is placed on top of the water drop and is touched to the surface of the layer, and pH is measured after 5 minutes, giving a pH of 2 0
[0104] Example 3. A polyethylene flat sheet of 0.5 mm thick is chlorosulfonated by immersing for six hours at room temperature in a sulfur dioxide/chlorine gas mixture (3:1 volume ratio) in visible light. The chlorosulfonated polyethylene sheet is then immersed in IN NaOH at 50°C. for two days to hydrolyze the pendant sulfonyl chloride groups (— SO2CI) groups to sulfonic groups (— SC>3Na+). The sulfonic acid form is obtained by treating the sheet with IN HC1 at room temperature for four hours. The sheet is then washed with deionized water and dried under vacuum. The milli-equivalence (meq) of sulfonic acid groups per gram of polyethylene is determined by titration with NaOH and found to be 1.69 meq/g. The sulfonated polyethylene sheet can be cut into appropriate sizes for the protection of surfaces.
[0105] Example 4. Diehl oromethane (50 mL, 66 gm) and chlorosulfonic acid (between 0.7 and 1.4 gms) are added sequentially to a wide mouth glass bottle (120 mL capacity, 2 inch diameter). 10 mL of this solution are added to dichloromethane (50 mL, 66 gms) in a wide mouth glass jar (410 mL, 3 inch diameter). To this mixture is added a 1 mil (0.001 inch, 0.0025 cm) colorless PPS (Polyphenylene Sulfide) film. The film is allowed to react for various amounts of time at 25° C. while being suspended in the reaction solution. After a variable time of reaction, the black film is then added to distilled water (200 mL) and the film turned light yellow. The film is washed extensively with more water (about 2 liter) and then boiled in water (250 mL) for about 1 hour. The film is then suspended in 1 molar sodium chloride (220 mL) and the amount of sulfonation is determined by titration with 0.01 molar sodium hydroxide to a pH 7 end point. The amount of sulfonation (in meq/g SO3H) with reaction-time is 0.64 (1 hour), 1.27 (6.5 hours), 1.71 (16 hours), 1.86 (24 hours), 2.31 (48 hours), and 2.6 (60 hours). The sulfonated poly(phenylene sulfide) film can be used for antimicrobial applications as coating materials or as protective films for use with face shields.
[0106] As used herein, the term “comprising” means including elements or steps that are identified following that term, but any such elements or steps are not exhaustive, and an embodiment can include other elements or steps. Although the terms “comprising” and “including” have been used herein to describe various aspects, the terms “consisting essentially of’ and “consisting of’ can be used in place of “comprising” and “including” to provide for more specific aspects of the disclosure and are also disclosed.
[0107] For the purposes of this specification and appended claims, unless otherwise indicated, all numbers expressing quantities, percentages or proportions, and other numerical values used in the specification and claims, are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained. It is noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the,” include plural references unless expressly and unequivocally limited to one referent. As used herein, the term “include” and its grammatical variants are intended to be non-limiting, such that recitation of items in a list is not to the exclusion of other like items that can be substituted or added to the listed items.
[0108] Unless otherwise specified, all technical and scientific terms used herein have the same meanings as commonly understood by one of skill in the art to which the disclosed disclosure belongs the recitation of a genus of elements, materials or other components, from which an individual component or mixture of components can be selected, is intended to include all possible sub-generic combinations of the listed components and mixtures thereof.
[0109] The patentable scope is defined by the claims, and can include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal languages of the claims. To an extent not inconsistent herewith, all citations referred to herein are hereby incorporated by reference.

Claims

1. A face shield comprising: a transparent face panel configured to extend facing at least a portion of a face of a wearer, the transparent face panel comprising: a substrate having a first surface adapted to be disposed facing the face of the wearer and second surface disposed opposite to the first surface, and at least one of first surface and the second surface is protected by a sulfonated polymeric layer for killing at least 90% microbes within 120 minutes of contact with the transparent face panel; and wherein the sulfonated polymeric layer consists essentially of a sulfonated polymer, the sulfonated polymer from the group of perfluorosulfonic acid polymers, polystyrene sulfonates, sulfonated block copolymers, sulfonated polyolefins, sulfonated polyimides, sulfonated polyamides, sulfonated polyesters, sulfonated polysulfones, sulfonated polyketones, sulfonated poly(arylene ether), and mixtures thereof, the sulfonated polymer has a degree of sulfonation of > 10%; wherein the sulfonated polymeric layer has a thickness of at least > 1 pm.
2. The face shield of claim 1, wherein the sulfonated polymer has an ionic exchange capacity (IEC) of > 0.5 meq/g.
3. The face shield of claim 1, wherein the sulfonated polymeric layer has a thickness of at least > 5 pm to kill > 95% of microbes within 120 minutes of contact after six months of protection.
4. The face shield of claim 1, wherein the sulfonated polymer has a degree of sulfonation of 10-100 mol %.
5. The face shield of claim 1, wherein the sulfonated polymer is a selectively sulfonated negative-charged anionic block copolymer having a general configuration of: A-B-A, (A-B)n(A), (A-B-A)n, (A-B-A)nX, (A-B)nX, A-D-B, A-B-D, A-D-B-D-A, A-B-D-B-A, (A-D- B)nA, (A-B-D)nA (A-D-B )nX, (A-B-D)nX or mixtures thereof, wherein n is an integer from 0 to 30,
X is a coupling agent residue, each A and D block is a polymer block resistant to sulfonation, each B block is susceptible to sulfonation, the A block is selected from polymerized (i) para-substituted styrene monomers, (ii) ethylene, (iii) alpha olefins of 3 to 18 carbon atoms; (iv) 1,3-cyclodiene monomers, (v) monomers of conjugated dienes having a vinyl content less than 35 mol percent prior to hydrogenation, (vi) acrylic esters, (vii) methacrylic esters, and (viii) mixtures thereof; the B block is a vinyl aromatic monomer, and the D block is a hydrogenated polymer or copolymer of a conjugated diene selected from isoprene, 1,3-butadiene and mixtures thereof; and wherein the block B is selectively sulfonated to contain from 10 - 100 mol % sulfonic acid or sulfonate salt functional groups based on the number of monomer units, for the coating material to kill at least 99% of microbes within 30 minutes of contact.
6. The face shield of claim 1, wherein the sulfonated polymeric layer has a surface pH of < 3.0.
7. The face shield of claim 1, wherein the the sulfonated polymer is neutralized with at least a salt selected from ammonium, phosphonium, pyridinium, and sulfonium salts.
8. The face shield of any of claims 1-7, wherein the sulfonated polymeric layer is applied onto one of the first surface and the second surface by dip coating, spray coating, dispersion coating, solvent casting, or adhesively attached as a peel-and-stick film.
9. The face shield of any of claims 1-7, further comprising an attachment structure coupled to the face panel and configured to secure the face panel in front of the face of the wearer.
10 The face shield of any of claims 1-7, wherein the attachment structure is an elastic band attached to a first and second side edges of the face panel.
11. The face shield of any of claims 1-7, wherein the attachment structure includes a first strap attached to a first side edge of the face panel, a second strap attached to a second side edge of the face panel, and a coupler having a first member attached to the first strap and a second member attached to the second strap and adapted to removably engage with the first member to facilitate the engagement of the attachment structure with the wearer’s head.
12. The face shield of any of claims 1-7, wherein the transparent face panel is removable.
13. The face shield of any of claims 1-7, wherein the attachment structure comprises any of: a cap adapted to be worn over the wearer’s head with the face panel adapted to be removably engaged with the cap; an eyeglass frame removably engaged with the face panel; a hook-and-loop fastener assembly; and a protective garment to be worn by the wearer.
14. The face shield of any of claims 1-6, wherein the substrate forming the face panel comprises a material selected from the group of polyesters, polycarbonates, allyl diglycolcarbonates, polyacrylates, polystyrenes, cellulose acetate butyrate, glass, and combinations thereof, and wherein the substrate forming the face panel has a thickness ranging from 0.001 to 2 mm.
15. The face shield of any of claims 1-6, wherein the first surface facing the face of the wearer is protected by a sulfonated polymeric layer having a Tf0 of > 15 minutes.
PCT/US2021/070409 2020-04-17 2021-04-19 Self-disinfecting face shield WO2021212149A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN202180028933.XA CN115484845A (en) 2020-04-17 2021-04-19 Self-disinfecting mask
JP2022562731A JP2023522333A (en) 2020-04-17 2021-04-19 Self-disinfecting face shield
EP21727067.7A EP4110126A1 (en) 2020-04-17 2021-04-19 Self-disinfecting face shield
US18/047,123 US20230085444A1 (en) 2020-04-17 2022-10-17 Self-Disinfecting Face Shield

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202063011576P 2020-04-17 2020-04-17
US63/011,576 2020-04-17
US202063019634P 2020-05-04 2020-05-04
US63/019,634 2020-05-04
US202163145801P 2021-02-04 2021-02-04
US63/145,801 2021-02-04

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/047,123 Continuation-In-Part US20230085444A1 (en) 2020-04-17 2022-10-17 Self-Disinfecting Face Shield

Publications (1)

Publication Number Publication Date
WO2021212149A1 true WO2021212149A1 (en) 2021-10-21

Family

ID=76035163

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/070409 WO2021212149A1 (en) 2020-04-17 2021-04-19 Self-disinfecting face shield

Country Status (5)

Country Link
EP (1) EP4110126A1 (en)
JP (1) JP2023522333A (en)
CN (1) CN115484845A (en)
AU (1) AU2021102028A4 (en)
WO (1) WO2021212149A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111223544A (en) * 2019-12-31 2020-06-02 创业慧康科技股份有限公司 Remote real-time endoscope safety consultation system
EP4239016A1 (en) * 2022-02-09 2023-09-06 Kraton Polymers Nederland B.V. Erasable and reusable marking surface

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492785A (en) 1982-12-29 1985-01-08 Exxon Research And Engineering Co. Water soluble block polymers
US4505827A (en) 1983-09-19 1985-03-19 The Dow Chemical Company Triblock polymers of the BAB type having hydrophobic association capabilities for rheological control in aqueous systems
US5516831A (en) 1991-01-30 1996-05-14 Shell Oil Company Selectively sulfonated block copolymers/extender oils
US6110616A (en) 1998-01-30 2000-08-29 Dais-Analytic Corporation Ion-conducting membrane for fuel cell
US20030203991A1 (en) * 2002-04-30 2003-10-30 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US7737224B2 (en) 2005-07-22 2010-06-15 Kraton Polymers U.S. Llc Sulfonated block copolymers, method for making same, and various uses for such block copolymers
US8012539B2 (en) 2008-05-09 2011-09-06 Kraton Polymers U.S. Llc Method for making sulfonated block copolymers, method for making membranes from such block copolymers and membrane structures
US8263713B2 (en) 2009-10-13 2012-09-11 Kraton Polymers U.S. Llc Amine neutralized sulfonated block copolymers and method for making same
US8445631B2 (en) 2009-10-13 2013-05-21 Kraton Polymers U.S. Llc Metal-neutralized sulfonated block copolymers, process for making them and their use
EP2947483A1 (en) * 2013-01-17 2015-11-25 Dexerials Corporation Optical element for facial protection
US9849450B2 (en) 2010-07-04 2017-12-26 Dioxide Materials, Inc. Ion-conducting membranes
US9861941B2 (en) 2011-07-12 2018-01-09 Kraton Polymers U.S. Llc Modified sulfonated block copolymers and the preparation thereof
US10202494B2 (en) 2015-10-15 2019-02-12 Kraton Polymers U.S. Llc Block copolymers having amine or phosphine functionalized end blocks
US10228168B2 (en) 2013-03-25 2019-03-12 Carrier Corporation Compressor bearing cooling

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492785A (en) 1982-12-29 1985-01-08 Exxon Research And Engineering Co. Water soluble block polymers
US4505827A (en) 1983-09-19 1985-03-19 The Dow Chemical Company Triblock polymers of the BAB type having hydrophobic association capabilities for rheological control in aqueous systems
US5516831A (en) 1991-01-30 1996-05-14 Shell Oil Company Selectively sulfonated block copolymers/extender oils
US6110616A (en) 1998-01-30 2000-08-29 Dais-Analytic Corporation Ion-conducting membrane for fuel cell
US20030203991A1 (en) * 2002-04-30 2003-10-30 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US8058353B2 (en) 2005-07-22 2011-11-15 Kraton Polymers Us Llc Sulfonated block copolymers method for making same, and various uses for such block copolymers
US8329827B2 (en) 2005-07-22 2012-12-11 Kraton Polymers U.S. Llc Sulfonated block copolymers having ethylene and diene interior blocks, and various uses for such block copolymers
US7981970B2 (en) 2005-07-22 2011-07-19 Kraton Polymers Us Llc Sulfonated block copolymers having acrylic esterand methacrylic ester interior blocks, and various uses for such blocks, and various uses for such block copolymers
US8003733B2 (en) 2005-07-22 2011-08-23 Kraton Polymers Us Llc Process for preparing sulfonated block copolymers and various uses for such block copolymers
US8383735B2 (en) 2005-07-22 2013-02-26 Kraton Polymers Us Llc Sulfonated block copolymers, method for making same, and various uses for such block copolymers
US7737224B2 (en) 2005-07-22 2010-06-15 Kraton Polymers U.S. Llc Sulfonated block copolymers, method for making same, and various uses for such block copolymers
US8084546B2 (en) 2005-07-22 2011-12-27 Kraton Polymers U.S. Llc Method for varying the transport properties of a film cast from a sulfonated copolymer
US7919565B2 (en) 2005-07-22 2011-04-05 Kraton Polymers U.S. Llc Composition containing sulfonated block copolymers and articles made therefrom
US8377514B2 (en) 2008-05-09 2013-02-19 Kraton Polymers Us Llc Sulfonated block copolymer fluid composition for preparing membranes and membrane structures
US8377515B2 (en) 2008-05-09 2013-02-19 Kraton Polymers U.S. Llc Process for preparing membranes and membrane structures from a sulfonated block copolymer fluid composition
US8012539B2 (en) 2008-05-09 2011-09-06 Kraton Polymers U.S. Llc Method for making sulfonated block copolymers, method for making membranes from such block copolymers and membrane structures
US8263713B2 (en) 2009-10-13 2012-09-11 Kraton Polymers U.S. Llc Amine neutralized sulfonated block copolymers and method for making same
US8445631B2 (en) 2009-10-13 2013-05-21 Kraton Polymers U.S. Llc Metal-neutralized sulfonated block copolymers, process for making them and their use
US9849450B2 (en) 2010-07-04 2017-12-26 Dioxide Materials, Inc. Ion-conducting membranes
US9861941B2 (en) 2011-07-12 2018-01-09 Kraton Polymers U.S. Llc Modified sulfonated block copolymers and the preparation thereof
EP2947483A1 (en) * 2013-01-17 2015-11-25 Dexerials Corporation Optical element for facial protection
US10228168B2 (en) 2013-03-25 2019-03-12 Carrier Corporation Compressor bearing cooling
US10202494B2 (en) 2015-10-15 2019-02-12 Kraton Polymers U.S. Llc Block copolymers having amine or phosphine functionalized end blocks

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Determination of the ion exchange capacity of anion-selective membrane", INTERNATIONAL JOURNAL OF HYDROGEN ENERGY, vol. 39, no. 10, 26 March 2014 (2014-03-26), pages 5054 - 5062

Also Published As

Publication number Publication date
CN115484845A (en) 2022-12-16
AU2021102028A4 (en) 2021-06-10
EP4110126A1 (en) 2023-01-04
JP2023522333A (en) 2023-05-30

Similar Documents

Publication Publication Date Title
AU2021102028A4 (en) Self-Disinfecting Face Shield
US20230167343A1 (en) Self-sterilizing protection for surfaces
US5997621A (en) Coating composition having anti-reflective and anti-fogging properties
AU711689B2 (en) Coating composition having anti-reflective and anti-fogging properties
JP3096125B2 (en) Transparent retroreflective sheet material and method for producing the same
CA2695962A1 (en) Vent and strap fastening system for a disposable respirator
JP2000503050A (en) Coating composition having anti-reflective and anti-fog properties
US20210355342A1 (en) Bio-secure protective equipment and methods for making
AU2021102026A4 (en) Bio-secure protective equipment and methods for making
US20230085444A1 (en) Self-Disinfecting Face Shield
AU2021102029A4 (en) Antimicrobial Face Mask
DE202021001417U1 (en) Self-disinfecting face shield
JP2012529577A (en) New product
AU2021102031A4 (en) Air Filter Device Incorporating Anti-Microbial Filter Media
KR102150598B1 (en) Body temperature sensitive washing container
AU2021102033A4 (en) Self-sterilizing wound dressing
EP4163339A1 (en) Coating film and article with coating film formed on surface
WO2021212155A1 (en) Antimicrobial paint composition
EP4223123A1 (en) Antimicrobial substrates
DE202021001418U1 (en) Antimicrobial face mask
AU2021102032A4 (en) Antimicrobial Spray Composition
JP7149678B1 (en) antibacterial or antiviral sheet
DE202021001422U1 (en) Self-sterilizing wound dressing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21727067

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021727067

Country of ref document: EP

Effective date: 20220928

ENP Entry into the national phase

Ref document number: 2022562731

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE